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Abstract
This thesis presents my research on the development and application of state-of-
the-art machine learning methods for the classification and analysis of murine
complementarity-determining regions 3 (CDR3) repertoires. Using classification
methods, I investigated the role and mechanisms of the CDR3 protein sequence.
These are short protein regions present on the T-cell receptor (TCR), and I have
aimed to identify the amino acids and positions that play a major role in the TCR,
allowing it to recognise specific antigens and to activate the adaptive immune re-
sponse.
The analyses performed are based on three different methods of machine learn-
ing: (i) The Support Vector Machine, used to carry out the classification analysis;
(ii) An application of Bayesian theory, to isolate the most relevant CDR3 features;
(iii) Markov chain and Hidden Markov Models, to study the variability of the reper-
toires and to identify specific regions of interest within the CDR3.
All of these methods have proved useful and have helped me to identify dif-
ferent features of the CDR3 repertoires. Indeed, specific position and combination
of amino acid have been identified and considered relevant for repertoires classi-
fication. It has been detected the presence of three different levels of emerging
conserved-areas in the CDR3, and investigated the role of the glycine and other
amino acids within motifs and putative interaction site. Although the biological
mechanisms of CDR3 are still not fully understood, my contribution to the field has
been to increase our understanding of CDR3, including the identification of rele-
vant position for the CDR3 interaction; motifs and patterns for the different groups
of mice repertoires; and an improved overall classification of such repertoires.
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Thesis Aim
Thanks to recent advances in high throughput DNA sequencing [1][2] and the im-
pressive fall in the cost of sequencing [3], there has been a rapid increase in the size
of TCR repertoires sequenced [4][5][6][7]. At this, exponential data growth must
now follow an improvement in methods of analysis. Current methods fall short
while analysing large repertoires and, like in the case of CDR3 repertoires, this is
present and broadened, missing the potential that a large collection of data can offer.
Thus far, the repertoire analysis considers the CDR3 sequences as the smallest
and most indivisible element of the repertoire. On this “atomic” element have been
conducted all kinds of statistical investigation. Studies have inferred and revealed
precious information such as the number of unique CDR3 sequences; whether they
are rare or common; if they are shared among repertoires [8]; assessed theories
on the mechanism of immune reaction, identifying, for example, that the immune
responses are carried by a mixture of public and private specificities [9][10][11].
However, there are significant limitations to this approach. First, the “se-
quence similarity”: two not-equal but very similar CDR3 that could potentially
recognise the same antigen would be considered completely unrelated. It is well
known that there are functional and structural hotspots, on peptides and CDR3s
alike, that are fundamental for the TCR and pMHC (MHC carrying a peptide) in-
teractions [12][13]. However, due to a lack of specific methods, this aspect is often
missed. The second limitation is “motifs and size”: in order to compare different
protein sequences, the most common procedure is to try to identify shared domains,
motifs or conserved elements. In bioinformatics, this is usually achieved by cre-
ating a multiple sequence alignment (MSA) [14]. However, these approaches are
Thesis Aim 16
not immediately applicable to CDR3 repertoires, because the number of proteins
sequenced is too high and the sequences too short and diverse to allow for meaning-
ful multi-alignment [15]. Third, the “repertoires similarity”, comparison between
repertoires is difficult and often completely ignored, preferring to focus on the se-
quences present within them.
There is, therefore, a need for developing of new methods that go beyond the
analysis of entire CDR3s. Most importantly, new methods are needed that can iden-
tify the amino acids and positions within the CDR3 that play a key role in antigen
discrimination and detection using a more “subatomic” approach, i.e. starting from
the single amino acid and extending to larger patch of the sequence.
To accomplish these tasks, I chose to design and apply methods for the clas-
sification of CDR3 repertoires. Being able to correctly classify different types of
repertoires gives us two important opportunities: first, the possibility of classifi-
cation could open relational studies among the repertoires as well as investigation
of the immune response against different antigens and exploring how immune re-
sponse begins and mutates. Second, classification would enable us to look within
each repertoire and investigate the “features” (specific amino acids and/or positions)
that made the classification possible and see if these elements have a biological rel-
evance for the immune response. These opportunities can help improve our under-
standing of the immune response and our ability to predict it.
Thesis Outline
1. Part I Biological Introduction: A functional description of T cells, T-cell
receptors and CDR3. This part introduces the biological background needed
to understand the aims of the projects:
1.1 An overview of the immune system: Chapters 1.
1.2 A deeper focus on the adaptive immune system: Chapter 2.
1.3 A focus on the T cells: Chapter 3.
2. Part II Results: A summary of the database used, and the main results ob-
tained. Each of the main results is presented in the form of a summary of the
methods, workflow and conclusions.
2.1 Analysis of the CDR3 dataset: Chapter 4.
2.2 Review of [16] and application of the Support Vector Machine as possi-
ble classification method for CDR3 repertoires:
2.2.1 Support Vector Machines: Chapter 5.
2.2.2 Bag of Wards: Chapter 6.
2.2.3 K-means algorithm: Chapter 7.
2.2.4 Experiments, workflow and results: Chapter 8.
2.3 Bayes’ theorem and its application as feature selection for SVM classi-
fication.
2.3.1 The Bayes’ theorem: Chapter 9.
2.3.2 Bayes’ theorem as classification method: Chapter 10.
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2.3.3 Feature selection using one dimensional naı¨ve Bayes’ classifier in-
creases the OSR of support vector machine classification of CDR3
repertoires: Chapter 11. See [17] for more.
2.4 The Hidden Markov Model as a way to identify CDR3 motifs and clas-
sify them.
2.4.1 Markov Chains: Chapter 12.
2.4.2 Hidden Markov Model Theory: Chapter 13.
2.4.3 HMM-Based Programs Utilised: Chapter 14.
2.4.4 Experiments with Hammock: Chapter 15.
2.4.5 Hammock Results as features of an SVM classification test: Chap-
ter 16.
3. Part III Discussion: Summary of the conclusions for each chapter and ideas
for further analysis: Chapter 17.
The structure of this thesis reflects approximately my three years of doctoral
research, with the repertoires analysis and SVM in my first year, Bayes’ theorem in
the second and HMM in my third. I will give in these chapters a clear explanation
of the experiments as well as a description of the evolution of thinking that led me







In this chapter, I briefly summarise the main features of the immune system, then
focus on the T-cell receptor (TCR) and one of its most important components: the
complementarity-determining region (CDR). Here, I refer primarily to the immune
system in humans and, where specified, to the murine immune system.
1.2 Introduction
As old as life itself, all organisms have developed mechanisms to defend themselves
from external intruders. Collectively, these mechanisms form the immune system of
the organism, which has the role of stopping any pathogen that could cause harm or
death to the host [18][19][20]. The word immune comes from the Latin, immunitas
[21], which means to exempt, or to be free from, and it identifies the vital need for
the organism to separate what belongs to the organism, called “self” and what does
not, called “non-self”. The need to protect the organism from possible threats has
resulted, through evolution, in many forms of defence, with different approaches
and degrees of complexity. Modern immunology divides the immune system into
two broads, and at times overlapping, categories: the innate immune system and the
adaptive immune system.
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1.3 The innate immune system
The innate immune system is the most ancient form of immune defence. It is present
in all classes of animals and plants in different forms and degrees of complexity.
Even the smallest organisms have some form of mechanism to deal with possible
intruders and to protect the organism from the external threats. As the word innate
suggests, the defence mechanisms are already present and functional within the
organism, before any threat is even encountered. Therefore, it can be immediately
activated and begin the fight as soon as the intrusion is detected.
An important characteristic of the innate immune system is that, although the
defence mechanism is already present and ready to respond to an external threat, the
response to a threat is generally similar to previous ones, without providing a better
or faster reaction to a subsequent encounter. This is the major point of difference
between the innate and adaptive immune systems, as we will see in the next section.
Within the innate system, the easiest and most effective instrument to avoid in-
fections is to prevent the intrusion of pathogens in the first place. This is performed
using physical barriers to separate the organism from the outside world. This is the
primary function of the skin that, when intact, is impermeable to most infectious
agents. The skin can also produce sebum that, with its low pH, acts as an additional
barrier against bacteria and viruses.
The defensive lines of our body are not only made by physical barriers but
also chemical barriers, such as the mucus, secreted by the membrane in the internal
surfaces, or other humoral fluid containing bactericidal substances including tears,
saliva and nasal secretions. These are usually connected to mechanical systems
such as blinking, coughing and sneezing. These mechanisms provide a first valid
protection; however, many infectious agents can enter the body through wounds,
gastrointestinal and urogenital tracts, or the respiratory epithelium, which is the
case for the common cold.
When a pathogen overcomes the epithelial barriers and infects the body, many
mechanisms of the innate immune system are immediately activated. For exam-
ple, the blood contains several classes of soluble molecules that can kill or weaken
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pathogens. These include antimicrobial enzymes, such as lysozyme, which can
digest bacterial cell walls; antimicrobial peptides such as the defences that lyse bac-
terial cell membranes; and a system of plasmatic proteins known as the complement
system, which can target pathogens both for lysis and for phagocytosis by employ-
ing cells of the innate immune system such as macrophages. These mechanisms are
part of what is called humoral immunity, the part of the immune system that resides
in the tissue fluids.
The complement system is one of the major defence systems in the body. It
is a complex and intricate system, with a large number of functions. The comple-
ment system can trigger and amplify inflammation reaction, direct microbial killing,
attract phagocytes, and help the development of an antibody response (one of the
many links between the innate and adaptive immune systems).
The innate immune system is not only composed of humoral immunity but also
a complex system of immune cells floating in the blood and tissue, forming what is
called cellular immunity.
1.4 The myeloid lineage: Cells of the innate immune
system
Both innate and adaptive immune responses are based on the activities of white
blood cells, also known as leukocytes [18]. All cells of the immune system originate
in the bone marrow and, with a few exceptions, also develop and mature there.
Leukocytes migrate to the peripheral tissues, circulating in the bloodstream or in
a specialized system called the lymphatic system, which carries the lymph, a fluid
containing white cells, around the body. Within the lymphatic system are present the
lymphatic organs such as the spleen, which produces an immune response through
the production of antibodies, and the thymus, in which the maturation of T cells
occurs.
All cells of the blood, including red blood cells for oxygen transportation,
platelets that repair damaged tissues, and white blood cells of the immune system,
derive from the hematopoietic stem cells of the bone marrow, known as pluripotent
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Figure 1.1: Diagram of human haematopoiesis from stem to mature cells: In humans,
the haematopoietic stem cells are located in the medulla of the bone marrow
and have the ability to differentiate in all types of mature blood cells and tissues
[22].
In the first stage of haematopoiesis the cell differentiates into either the com-
mon myeloid progenitor or the common lymphoid progenitor. The first (present
on the left-hand side of the tree) produces two lineages: the cells of the myeloid
lineage known as granulocytes, megakaryocytes and macrophages that are in-
volved as innate immunity and the erythrocyte, or red blood cells. The second
(on the right-hand side) produce the adaptive immune system cells, T cells, B
cells and Natural killer cells. Figure source [23].
hematopoietic stem cells. They differentiate into stem cells of less developmental
potential that are the immediate progenitors of red blood cells, platelets, and the two
main categories of white blood cells, the lymphoid lineages and myeloid lineages.
See Figure 1.1.
The common myeloid progenitor is the precursor of the macrophages, granulo-
cytes, mast cells and dendritic cells of the innate immune system, and of megakary-
ocytes and red blood cells, which will not be explained in this thesis.
Macrophages are relatively long-lived cells, present in almost all tissue. They
perform several functions of the innate immune response and are also connected
with the adaptive immune response. Their main task is to engulf and kill invad-
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ing microorganisms by what is called phagocytosis. They literally surround, en-
gulf and digest the pathogen and the infected cells targeted by an adaptive immune
response. They also coordinate the immune response by inducing inflammation,
which secretes proteins that activate other immune-system cells, such as cytokines,
and recruit other cells to an immune response site.
The granulocytes are so called because of the presence of several dense and
colourful granules in the cytoplasm; they are also called polymorphonuclear leuko-
cytes because of their oddly shaped nuclei. There are three types of granulocytes
—neutrophils, eosinophils, and basophils —which are distinguished by the differ-
ent colour properties of the granules. They are all relatively short-lived, typically for
a few days, and are produced during immune responses, when they leave the blood
to migrate to sites of infection or inflammation, where pathogens and infected cells
are to be found.
The dendritic cells (DC) have long finger-like protuberances, like the dendrites
of nerve cells, which give them their name (from the Greek dendron, meaning “tree”
[24]). Immature DC migrate through the peripheral blood from the bone marrow
to the tissues. As for macrophages and neutrophils, DC also engulf the pathogens.
However, their main purpose is not to eliminate the infectious pathogen by direct
phagocytosis, but to present chunks of the digested pathogen to a class of lympho-
cyte cells called the T lymphocytes. The pieces of pathogen exposed on the DC
surface are called antigens.
Therefore, the DCs and other cells, such as macrophages and B cells, are also
called “antigen presenting cells” or APCs. The DC is the most important cell type in
this class, the act of presentation being the main function of the DC. This is one of
the most important links between the innate and the adaptive immune system, sup-
plying clear clues to the pathogen kind and its characteristics, allowing the adaptive
system to develop an effective and precise response.
Chapter 2
The adaptive immune system
The adaptive immune system is the second typology of immune system present in
humans, as well as all jawed vertebrates. The adaptive system is not an alternative
or unrelated type of immune system in respect to the innate. On the contrary, both
systems work together for the common goal of protecting the host. The feature
which distinguishes the adaptive system is its ability to create specific and targeted
responses to new threats, discerning what belongs to the host, thus “self”, from what
does not, “not-self”, and to remember those threats already encountered (immuno-
logical memory).
If the innate response is fast, immediate, available and gives a generic response,
the adaptive response is instead much slower, needing to develop a specific reaction.
However, this delay occurs only on the first encounter. After that, the system can
remember the event, even for the entire lifespan of the host, and give a rapid re-
sponse at a second encounter. This capacity, for instance, is what accounts for the
success of vaccination [25]. Therefore, the power of the adaptive system is reliant
on its ability to fight new pathogens, and to recognise and remember old threats.
2.1 The lymphoid lineage: Cells of the adaptive im-
mune system
As we have already seen (Figure 1.1), the pluripotent hematopoietic stem cell dif-
ferentiates into a myeloid and lymphoid lineage, the latter being much simpler com-
pared to the myeloid, and presenting fewer types of cells: the Natural Killer cells
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and the cells of the adaptive immune system T and B.
The Natural Killer (NK) cells form 15% of all lymphocytes present in the
blood, and it has a peculiar granular cytoplasm, reminiscent of that present in the
granulocytes. Although deriving from the same common progenitor of T and B
cells, the NK are considered part of the innate immune system. NK are principally
involved in the elimination of intracellular pathogens, host cells infected by viruses,
and some abnormal cells; for example, some tumour cells.
The last group of cells are the lymphocytes T and B. These two kinds of cells
are also known as antigen-specific lymphocytes for their peculiar characteristic of
being able to recognise and bind a large diversity of antigens, using the receptors
on their cellular surface. These receptors are the special tools that allow these lym-
phocytes to recognise, by direct physical contact, what belongs to the host and what
does not. When recognition occurs, the lymphocytes become activated, and differ-
entiate further into fully functional lymphocytes, known as effector lymphocytes.
Each lymphocyte carries only a single type of receptor and its effectiveness is
limited to a few epitopes (the part of the antigen recognised by the receptor). There-
fore, the adaptive system relies on the great number and variability of lymphocytes
circulating at any given moment in the blood, presenting a valid defence to any
possible threat to the host.
There are two types of lymphocytes: B lymphocytes (B cells) and T lym-
phocytes (T cells), with different roles and maturation place, and distinct types of
antigen receptors.
B cells develop in the bone marrow, its name coming from the bursa of Fabri-
cius [26], a lymphoid organ present in birds where these cells were originally dis-
covered.
The functions of the B cell are the production and secretion of antibodies (Ab),
one of the main components of the humoral immunity component of the adaptive
system, the release of cytokines and the presentation of antigens; B cells are con-
sidered professional APCs.
On the surface of the B cell is present a receptor called a B-cell receptor (BCR).
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The B cell circulates in the body scanning the surrounding environment with its
BCR, looking for not-self antigens. Once the BCR bonds with an antigen the B cell
will proliferate and differentiate into a plasma cell, the smaller part into memory B
cells. Plasma cells are the effector form of the B cells, attacking the pathogen by
secreting antibodies.
Antibodies are Y-shaped molecules with two branches and an antigen speci-
ficity sites on the tips of each branch. These sites are identical to the B-cell recep-
tor. Therefore, the antigen that activates a given B cell becomes the target of the
antibodies produced by the plasma cell.
A major role of the antibodies in adaptive immunity is to help the other cells of
the immune system to see and engulf the microbe or the infected cell. Antibodies
binding to their antigens can flag these cells and make their elimination much easier.
Chapter 3
The T Cell
3.1 T cells, functions and typologies
The T cell, together with the B cell, is the other of the two cells of the adaptive im-
mune system. Thanks to their wide range of functions, the T cells can be considered
one of the most important cells inside the immune system. Indeed, the T cell is one
of the main protagonists in the activation, regulation, memory and killing process
of the adaptive immune system.
Once the T cell is activated by an antigen recognition, it differentiates into
several different subtypes of cells: we can gather them into four broad categories:
• The Helper T cells (TH). This is a large subgroup of T cells, containing many
subtypes such as TH1, TH2, TH3, TH17, TH9, or TFH . As their name sug-
gests, the function of the cells is to “help”, to sustain and guide the immune
reaction. After T cells have been activated by the APCs, the cells differenti-
ate into one of the many subtypes of TH , which rapidly divide and secrete a
large number of cytokines. Doing that, they can mediate the cytotoxicity and
inflammation, and stimulate B cells to proliferate and produce antibodies.
The most common subtypes of TH are the TH1 and the TH2. The first is
responsible for defence against intracellular viral and bacterial pathogens, the
second against large extracellular pathogens and allergic responses.
• Regulatory T cells (TReg). If TH has the role of sustaining the immune re-
sponse, TReg has the role of suppressing it, by inhibiting the proinflammatory
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T cells, suppresses autoreactive T cells that escaped the process of negative
selection, preventing autoimmune disease.
• The Cytotoxic T lymphocytes (CTLs), or T Killer cell. These cells are
responsible for the direct destruction of virus-infected cells, damaged or tu-
mour cells. Host cells infected by intracellular pathogens would express a
molecular named MHC class I (we will it see later), that is recognised by
the CTLs. This is crucial for the body; indeed, intracellular pathogens are
generally overlooked by the innate immune system.
• The memory T cells. These are the T cells that develop after an encounter,
and persist for a long time inside the body, after the infection is concluded.
The function of this cell is to give a faster and stronger immune response in
a second encounter with the same antigen. This is the mechanism at the core
of the vaccination process [27].
3.2 T-cell development
Both T cells and B cells derive from the common lymphoid progenitor, as seen in
Figure 1.1, but unlike the B cells that mature in the bone marrow, the T cells migrate
from there to mature in the thymus.
The thymus is one of the primary lymphoid organs present in the human body:
where the lymphocytes would differentiate, proliferate, be selected and then mature
into functional cells.
The thymus is a bilobed organ, present in the thoracic cavity behind the ster-
num, just above the heart. Each of the two lobes is organised into lobules, divided
by connective tissue, and each lobule is divided into an outer cortex and an inner
medulla. The two areas of the lobules reflect the maturation of the T cells: in the
outer part are present the immature T cell, and the inner part the mature cells.
The process that leads the hematopoietic progenitor of the T cells (or thymo-
cytes) to mature into functional T cells is called thymopoiesis. This starts as soon
as the thymocytes migrate from the bone marrow and enter the thymus.
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The maturation of thymocytes requires progression through the different stages
of thymopoiesis. To mark these stages, it is possible to use the presence and ab-
sence of different kinds of surface glycoproteins, known as clusters of designation
or classification determinant (CD). For this thesis, we will focus primarily on CD4
and CD8, which have a role as co-receptors during the antigen presentation event,
and would determine the nature and function of the cell.
The thymopoiesis can be divided into three broad stages, depending on the
CD present on the surface of the cell. At the earliest stage, the thymocytes ex-
press neither CD4 nor CD8. For this reason, it is called the double-negative stage
(DN) (CD4−CD8−). Later, the T cell develops a second stage, called the double-
positive stage (DP)(CD4+CD8+), where both surface proteins are present. At the
end, the cell passes to a single-positive stage where only one of the proteins is
present (CD4+CD8− or CD4−CD8+). The cell is now mature and is released from
the thymus to peripheral tissues [28].
CD4 and CD8 are important for the stage classification and future nature of
the mature T cell. However, the significant event during T-cell development is the
production of a functional and non-self-reactive T-cell receptor (TCR). We have
already seen that the TCR plays a fundamental role in the immune system, recog-
nising what is considered to not be part of the body, and kick-starting the immune
response. Given this great importance, the production and selection of TCR is a
highly organised and regulated event.
The DN stage can be divided into four different stages, during which the thy-
mocyte proliferates, loses the B-cell and myeloid potential, and rearranges the β
chain (one of the two chain of the T cell) loci to produce a functional β chain. If the
β chain can successfully pair with an invariant form of α chain, the cell can pass
to the DP stage, otherwise the T cell is eliminated by apoptosis (β -selection stage).
The following DP stage is focused, instead, on the production of a functional α
chain. This chain will be tested to pair with the β chain, leading to apoptosis if an
error occurs and forming a TCR otherwise.
The TCR is now formed and must be tested to prove its functionality. The
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TCR passes through two series of selection that will determine if the cell can be
released into the body or eliminated. These selection processes are named positive
and negative selection.
During positive selection, the DP thymocytes interact with different Major
Histocompatibility Complex, a set of surface protein that carries antigens, present
in two classes: class I (MHC class I) or class II (MHC class II) and that are present
on the surface of the thymic cortical epithelial cells. If the thymocytes interact
with an appropriate intermediate affinity (not too strongly or too weakly) they are
considered suitable and not eliminated.
During this stage, it will be defined the glycoprotein that will be present on the
surface of the thymocyte. If it has interacted well with the MHC class II, the T cell
will become a CD4+ cell. Otherwise, it will mature into a CD8+ T cell.
During negative selection, the TCR are now tested not based on their affinity
to the antigen but based on which typology of antigen they are attracted to. The
negative selection must eliminate all the T cells capable of being activated by self-
peptides that will be naturally present in the body.
The negative selection happens in the medulla region of the thymus: here, the
medullary thymic epithelial cells present the MHCs carrying self-antigens. The thy-
mocytes that interact too strongly with the antigen will receive an apoptotic signal
leading to the death of the cell. Those interacting weakly are spared and will be-
come Regulatory T cells. With these two selections, the body ensures that the TCR
has been bound to the antigen with an adequate strength (positive selection) but do
not recognise an antigen belonging to the host (negative selection).
The thymopoiesis is, therefore, a very well organised process, where the TCR
is tested in all its aspects, with several checkpoints and control systems. It has been
calculated that only 2% of all thymocytes will survive to the thymopoiesis and leave
the thymus as mature T cells [19] .
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3.3 Antigen presentation
I briefly mentioned that the T cells are activated by the recognition of a not-self
antigen, and this antigen is presented to the TCR by the APC cells (dendritic cells,
macrophages, etc.).
Let us now explore the process in greater detail.
The event in which the APCs present the antigen to the T cell is called an
antigen presentation event. The elements involved are: the T-cell receptor (which
will be analysed in the next section); the major histocompatibility complex (MHC),
which is a surface protein present on the APCs that physically carries the antigen;
and the antigen itself.
Generally speaking, an antigen is defined as a molecule inducing an immune
reaction. The part of the antigen recognised by the TCR is called the epitope
(or antigenic determinant), and the part of the TCR/BCR recognising it is called
the paratope. An antigen can have different epitopes, and the same epitope can
be recognised by various T-cell receptors: this phenomenon is known as cross-
reactivity.
Antigens can derive from the external environment and internalised (exoge-
nous antigens) or can be generated inside the host cells due to viral or intracellular
bacterial infection (endogenous antigens). The antigen presented to the TCR by
the MHC is usually a short piece of protein: 8-10 amino acid for MHC class I and
13-24 for MHC class II.
The MHC molecules are a group of cell surface proteins essential for the im-
mune system. They are expressed by the APC cells for the antigen presentation,
and from the virus-infected cells. The principal function of the MHC molecules is
to bind the antigens derived from the degradation of the pathogens and display them
on the cell surface.
In humans, the MHC, are also known as human leukocyte antigens (HLA), be-
cause of their first identification as histocompatibility (transplantation) antigens on
the surface of leukocytes [30]. The most relevant class of MHC are the MHC class
I and II. These have a dissimilar structure and functions. MHC class I carries en-
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Figure 3.1: The interaction between CD4+ and CD8+ TCR and, MHC class I and II:
In this picture we can see the interaction between the TCRs, the clusters of
differentiation (CD) and the MHC class I and II. Despite the TCR being es-
sentially identical in both CD4+ and CD8+ T cells, a successful interaction is
aided when the CDs on their surface interact with the MHC.
On the surface of the T cells can be present only one kind of CD therefore, the T
cell can recognise only a type of MHC. This will decide the “fate” of the T cell.
Indeed, the MHC class I (left-hand side) can only bind endogenous antigens
and it can only be recognised by CD8 co-receptors (Cytotoxic T cells). While
MHC class II (right-hand side) carries exogenous antigens and it can only be
recognised by CD4 co-receptors (Helper and Regulatory T cells).
The CD4 is formed by four consecutive immunoglobulin domains, from D1
the most external, to D4 which is anchored to the surface. The CD8 is formed
by two chains: α and β , belonging to the immunoglobulin superfamily, and
an intracellular tail. MHC class I is formed by two polypeptide chains, α and
β2-microglobulin. While the MHC class II consists of two chain α and β , both
divided in two region α1, α2 and β1, β2. All these proteins are anchored to
the membranes by flexible chains and hinges, so that they can move around and
form this complex interaction. Source [29]
dogenous (or intrinsic) antigens, those antigens derived from viruses and pathogens
inhabiting the cell, while MHC class II carries antigens which are derived primar-
ily from exogenous sources, like extracellular pathogens (exogenous or extrinsic
antigens).
MHC class I is formed by three different extracellular domains (α1, α2, α3),
a transmembrane region and a cytoplasmic tail. MHC I can only bind endoge-
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nous antigens and can only be recognised by CD8 co-receptors, (Cytotoxic T cells).
MHC class II is instead formed by a α chain (heavy) and a β chain (light). It carries
exogenous antigens. It can only be recognised by CD4 co-receptors, (Helper and
Regulatory T cells). See Figure 3.1
The activation of TCR happens when it recognises the MHC-peptide complex,
together with other co-stimulatory signals.
3.4 TCR Structure
T-cell receptor is a heterodimer surface protein, formed by two polypeptides con-
nected by disulphuric bonds and anchored to the membrane by a small membrane
domain, and a very short cytoplasmic tail (Figure 3.2 b). It is structurally and func-
tionally similar to the BCR and antibodies belonging to the same family of im-
munoglobulin (Figure 3.2 a).
It is usually formed by a combination of α and β chains. αβ T cells make up
90-95% of all T cells of the peripheral blood in humans. The alternative form of T
cell is made by two similar polypeptides, the γ and δ chains, therefore called, γδ T
cell [18][31].
Both kinds of receptors are associated with a set of five polypeptides which
form the CD3 complex, all together forming the TCR-CD3 complex (Figure 3.2 b).
[18][32].
Each chain of the TCR is composed of a constant (C) region on the intracellular
side, and a variable (V) region on the extracellular face of the receptor. A key
characteristic feature of the V region of TCRs (and BCRs) is that their genes are
not functionally encoded in the germline. Instead each chain derives from several
non-contiguous DNA segments that are selected and recombined. However, TCR
gene selection is highly biased and not all combinations of genes are equally likely
[33].
The locus for the α chain contains two categories, or types, of segments: the
variable (V) and joining (J) segments. While for the β chain a third type is present
in addition to these two: the diversity (D) segment (Figure 3.2 c).
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Figure 3.2: The TCR structure, comparison and the CD3 complex: In this picture we
can see the structure of the TCR and the TCR-CD3 complex. In Sub-fig a:
the structure of the TCR and BCR are compared, both belong to the same fam-
ily of immunoglobulin, with similar structures made of a constant and variable
region. They also have a similar function, recognising antigens through their
binding site made by two CDR3s. Given the similarity of the latter, any under-
standing in the antigen-CDR3s interaction in one would help the study of the
other molecule. In Sub-fig b: the TCR-CD3 complex, the CD3s is reported.
The complex consists of a CD3 γ chain, a CD3 δ chain, and two CD3 ε chains.
These chains are associated with the ζ chain (zeta chain). Together those are
considered relevant for the transmission of the activation signals after peptide
binding to generate an activation signal in T lymphocytes. The TCR, ζ chain,
and CD3 molecules together constitute the TCR complex. In Sub-fig. c: the
structure of a β chain of the TCR is reported. In this chain the variable domain
is formed by one more region (D), absent in the α chain [18].
On the top of the variable domain on both chains three hypervariable [34]
regions are present, better known as complementarity-determining regions (CDR).
These six regions are considered very important for the recognition of, and the
interaction with, the pMHC. We will analyse these regions in greater detail in the
following sections.
As suggested by the presence of the CDRs, the variable region of the TCR is
more oriented to interaction with the MHC, while the constant region has more a
structural role, with the presence of disulphuric bonds between the two chains.
Because the TCR does not have a cytoplasmic domain capable of transmitting
a signal after interaction with the MHC, this role is entrusted to the CD3 proteins in
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the TCR complex. The cytoplasmic portions of the CD3 contain sequences called
ITAMs that are targets for protein kinases. These segments become phosphorylated
briefly after the TCR-MHC interaction, which produces physical changes in the
TCR structure, which in turn can propagate the signal [35].
3.5 V(D)J recombination
As mentioned, the function of the TCR is to recognise the not-self antigens present
in the host. However, it would be impossible for the host to encode in its genome a
different TCR sequence for each possible antigen.
In this scenario, the space needed in the genome would be enormous, while the
host would be vulnerable to any new mutation occurring in a pathogen. To avoid
this, evolution has provided a system that needs only a relatively small number of
genetic loci, that can be combined and rearranged in a way to produce a wide and
effective variation of TCRs within the repertoire.
This system is called V(D)J recombination. A schematic for TCR is repre-
sented in Figure 3.3.
The V(D)J recombination occurs to both B and T lymphocytes during their
development in the primary lymphoid organs: for the B cells in the bone marrow,
and for the T cells, during the thymopoiesis, as we have already seen. For both
lymphocytes, the system of V(D)J recombination is similar, producing a great range
of immunoglobulins and antibodies.
3.6 The number of TCR and T cells
The total number of T cells and TCR diversity in the human body and other animals,
especially in mice, has been one of the main debates regarding T cells in the last two
decades [36][37]. It has been noted that the value of clonotypes in the peripheral
blood changes with factors like ageing, pathogens and viral infection, immunisation
and transplantations [37][38][39][40][41]. For these reasons, a precise over-time
description of repertoire diversity would help in understanding how any of these
factors can influence our life and the fight against diseases.
The most common form of T cell in humans is the αβ T-cell receptor. The
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Figure 3.3: V(D)J recombination: Here is reported a schematic representation of the
V(D)J recombination: both α and β -chain genes are composed of discrete sec-
tions that are joined by somatic recombination during the T-cell development.
For the α chain (upper part of figure), a Vα gene segment rearranges to a Jα
gene segment to create a functional V region exon. Transcription and splicing
of the VJα exon to Cα generates the mRNA that is translated to yield the T-cell
receptor α-chain protein.
For the β chain (lower part), the variable domain is encoded in three gene
segments, V, D and J. Rearrangement of these gene segments generates a func-
tional VDJβ . V region is transcribed and spliced to join the Cβ ; the resulting
mRNA is translated to yield the T-cell receptor β chain.
The α and β chains pair soon after their biosynthesis to yield the α:β T-cell
receptor heterodimer. Source [18].
β -chain (TRB) locus is formed by 54 TRBV genes, 2 TRBD genes, 13 TRBJ genes
and 2 TRBC genes (see Table 3.1). The first step of beta recombination is the
recombination of one of the two D genes, Dβ1 and Dβ2, recombining respectively
with one of the six Jβ1 segment, or with one of seven Jβ2 segments. The DJ
recombination is followed by the rearrangement of one of the circa 50 Vβ gene
segments, with the Dβ Jβ already rearranged. All of that it is combined with one of
the two segments of the constant domain genes (Vβ -Dβ -Jβ -Cβ ).
The α-chain locus is composed of 47 V genes, 57 J genes and a single TRAC
(See Table 3.1). This resembles a V-to-J rearrangement with a lack of D segments,
but a prodigious number of J segment [42].
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Number of segments
Regions α Chain β Chain
Variable (V) 47 54
Diversity (D) - 1,1(2)
Joining (J) 57 6,7(13)
Constant (C) 1 2
Possible Combinations
Segments combinations 2,679 2,808
Merging α and β 7,522,632
P-N insertions 1015/1020
Table 3.1: Theoretical number of αβ TCR by the V(D)J recombination: In humans, the
TRA locus comprises 47 TRA (T-cell receptor alpha) V genes, 57 TRA-J genes
and a single TRA-C gene. VJ recombination can rearrange these 104 genes into
2,679 unique α-chain VJC gene combinations.
The T-cell receptor beta (TRB) locus contains 54 TRB-V genes, 2 TRB-D genes,
13 TRB-J genes and 2 TRB-C genes. VDJ recombination can rearrange these
71 genes into 2,808 unique β -chain VDJC gene combinations.
Merging all α and β chain would produce an impressive 7 million combinations.
Subsequent deletions and insertions of nucleotides at the junction section would
result in a theoretical repertoire of 1015/1020 different TCRs in humans. Data
source [42].
The entire process of the V(D)J recombination is mediated by a class of en-
zymes called VDJ recombinase, of which the most important are the recombination
activating genes (RAG) 1 and 2, the terminal deoxynucleotidyl transferase (TdT).
To proceed with the recombination, the recombinase makes use of special re-
gions flanking the gene segments for all V, D and J regions. Such regions are called
recombination signal sequences (RSSs), and they are formed by three elements: a
heptamer, that is, seven conserved nucleotides (CACAGTG); a nonamer, nine con-
served nucleotides (ACAAAAACC); and a region of 12 or 23 base pairs in length.
The nucleic acid composition of the 12/23 base pair is poorly conserved, but
12 and 23 base pair are approximately equal to one or two turns of a DNA helix.
This space is used by the recombinase enzymes and therefore it is referred to as
12/23 rule.
If we take the values in Table 3.1 and compute the possible combinations with
all segments we will find that for the α chains, 2,679 unique combinations of the 104
genes of VJ recombination are possible. For the β chain 2,808 unique sequences
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are possible. Finally, all the possible combinations of α and β chains can give rise
to a value of 7.5 ·106 TCRs [43].
The V(D)J recombination is a biased event [33]. Therefore, the body would not
produce each TCR with the same frequency. This could risk decreasing the possible
number of TCRs and the overall repertoire of variability. However, during the pro-
cess of recombination, the RAG enzymes break the DNA, making a single-strand
cut at the 3′-5′ end of the heptamer: DNA repair enzymes would add and/or remove
various nucleotides (insertion/deletion event), called palindromic (P) nucleotides,
while the TdT will add/remove non-templated (N) nucleotides to the 5′-3′ direction.
This event can boost the value of the theoretical repertoire to 1015-1018 dif-
ferent TCRs [41][42][43]. This large value exceeds even the number of cells in a
human body, and so, naturally, only a smaller number of combinations is present at
any given time.
Thanks to new modern sequencing techniques, such as high-throughput se-
quencing (HTS), the possibility of gaining a clearer insight into the number of dif-
ferent T cells in the blood has increased.
The latest value for T cells in the peripheral blood is around 1011 [37]. In-
cluded in this value are all T-cell clonotypes, thus all the T cells that share the same
TCR. Therefore, the total number of T cells is a value closer to 1010. In mice, the
total number of naı¨ve T cells in peripheral blood is 107, with the number of single
clonotypes about half the size [42].
3.7 The complementarity determining regions and
the MHC interaction
The variable region of the TCR is the part of the receptor used for the recogni-
tion of the MHC carrying the peptide. Thanks to studies on the multiple sequence
alignments of TCRs and antibodies [44], it has been possible to identify six specific
regions that interact directly with the MHC and the peptide.
These regions are poorly conserved, and for this reason they were orig-
inally named hypervariable regions. However, structural studies and X-ray
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crystallography-imaging showed that these regions are loops on the top of the
TCR, and they interact directly with the MHC and the peptide. Because of this,
they have been renamed Complementarity Determining Regions (CDRs) [45]. Al-
though they have been extensively studied, the precise mechanisms by which the
CDRs can bind the MHC and recognise the peptide are still largely unknown.
On each chain of the TCR are present three of these regions: CDR1, CDR2
and, CDR3 (Figure 3.4).
Figure 3.4: Particular of TCR V region and peptide: Above is illustrated the TCR V re-
gion interacting with a peptide (magenta). The three pairs of CDRs are pointed
out and we can see that the CDR3s (in red) are in direct contact with the pep-
tide, suggesting that these play a major role in the interaction with the peptides
while the CDR1 (in green) and CDR2 (in blue) are more involved with the
interaction with MHC. In yellow the β chain, in orange the α chain. Picture
produced with PyMol, PDB crystal structure ID: 4MNQ [46].
The three pairs of CDRs loops play different roles during the interaction with
the p:MHC. Their loops are arranged in different ways (see Figure 3.4) and have a
different role in the interaction.
The CDR1 and 2 are mainly involved with the binding of the MHC [12]. Both
loops work together to allow a correct orientation of the MHC and TCR, and then
to arrange the physical contact between the two molecules [47]. The CDR2s have
an exclusive contact with the central parts of the MHC, and are probably highly
relevant in the recognition of the MHC [48], while the CDR1s loops have a smaller
contact with the MHC, and a contact with the terminal part of the peptides [49]. The
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CDR1 of the α chain interacts directly with the N-terminal of the antigen, while the
CDR1 in the β chain can interact with the C-terminal part of the peptide [47].
CDR1 and CDR2 loops are very rigid loops, showing little or no rearrangement
for the binding process [48]. The binding between TCR and MHCs is mediated by
specific “contact points” present on specific positions on both molecules. It has also
been suggested that there are different “contact points” between the TCR binding
the MHC class I, and the TCR binding the MHC class II [12]. This and other clues
suggest that there could be two different binding mechanisms for CD4 and CD8
T-cell interactions and recognitions [48].
The CDR1 and 2 are considered fundamental for the docking of the two pro-
teins, but they only have a minor contribution for the recognition of the peptide.
What determines the stability of binding is the interaction between the peptide and
the last CDR, the CDR3 [48].
The CDR3s are defined as the piece of the TCR sequence between the last
conserved Cysteine at the end of the V segment, and the conserved FG[X]G motive
in the J segment [44][50]. This means that the D region of the TCR β chain is
present completely inside the CDR3 β segment [51]. The two CDR3s are positioned
on the centre of the top of the TCR molecule, and the two loops form a pocket where
the antigen can be allocated and interact directly with the TCR [52][53][54].
Formerly, because of the presence of the D region within the CDR3 beta, the
CDR3 repertoire was considered to be the greatest source of variability. However,
thanks to new crystal structures, this idea has been reconsidered, and the contribu-
tion to recognition is viewed as a product of equally-important and complex inter-
actions between the TCR α and β chains [51].
While the CDR1 and 2 are two rigid loops, the two CDR3 have great flexibility.
They are able to create different conformations and to “adapt” to different anti-
gens. This great ability makes it possible to extend the number of peptides that a
TCR can potentially recognise [47][51][55][56].
However, if the flexibility of the loops increases the number of peptides recog-
nised by a single TCR, what makes the entire TCR repertoire an effective system
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for peptide recognition is the great variability of the CDR3 repertoire.
Because of this, it has been possible to conduct studies where the same peptide
has been recognised by different CDR3s. These studies suggest that the interaction
between CDR3 and peptides is mediated by a few hydrogen bonds (H-bonds), by
the side-chain of CDR3 peptides, interacting with the backbone of the peptide, and
one (or rarely more) charge–charge interactions with the peptide [56].
These observations lead to the conclusion that within the binding surface there
are different parts with distinct contributions for the association and stabilization of
the protein complex. Such hotspot-like positions and interactions can explain how
the TCR can cross-react with many different types of peptides [57].
3.8 Cross reactivity
By cross-reactivity is meant the ability of a TCR to recognise different types of
peptides and MHC combinations (cognate ligands). This is similar to the cross-
reactivity that may happen when antibodies bind to different antigens [19][58].
The degree of cross-reactivity of a TCR, that is, how many different peptides
can the receptor recognise, can vary greatly, and in the TCR it is generally very
high. Each TCR can recognise hundreds of peptides, some estimations suggesting
even thousands. It has also been suggested that this degree of cross-reactivity might
be different between class I and class II MHC-specific TCRs [47].
The TCR cross-reactivity can be caused by the structural adjustment of TCR-
MHC docking. For example, flexible CDRs loops can accommodate different pep-
tides without altering the docking orientation [56][59]; the same TCR binds differ-
ent peptide-MHC ligands using different docking orientations [60] or, alternatively,
by molecular mimicry. Different peptide-MHC ligands can form very similar inter-
faces with partially identical amino acid sequences or structural similarities such as
size, charge, or hydrophobicity at certain positions [49][61].
Cross-reactivity has been explained as a way of expanding the effectiveness of
the TCR repertoire [62]. And because only by this phenomenon can the number of
peptides being recognised increase by a large margin, this is viewed as a necessary
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Figure 3.5: Three TCRs recognising the same peptide: This figure (originated by [47],
top part from Figure 5C, sequences from supplementary material) illustrates
the interaction between a singular peptide and three different TCRs and their
CDR3s.
In the paper the authors investigate the TCR cross-reactivity to give a first-
time measurement of it by identifying hundreds of peptides reactive with five
different murine and human TCR.
In the picture above three human TCRs interact with the same peptide despite
not identical CDR3s, with few different amino acid in the position directly
interacting with the peptide (in red). This result reinforces the idea that the
peptide recognition is driven by a small set of amino acids rather that the entire
CDR3 sequence.
technique for the body, almost a “biological imperative” [47].
Recent studies have shown that cross-reactivity relies on a lock-and-key-like
mechanism, where a minimal binding mechanism allows tolerance of a great vari-
ability of peptides, as long as the peptides conserve specific amino acids named
“hotspots” [47][57]. A similar concept is present in [61], where it has been found
that the peptides binding the same MHC need to share five amino acids to cross-
react to the same TCR. For instance, for the I-Ab MHC class II molecule, the
binding peptide has to conserve the positions (P2, P3, P5, P7, P8), with the P5
considered the most important because it interacts directly with the CDR3s [12].
Similar to the concept of hotspots on the peptides, the presence of conserved
amino acid on the CDR3s has been observed for TCRs reacting to the same peptide.
This is the case in [47], where a study concerning the crystal structure of different
TCRs recognising the same peptide has seen the presence of conserved amino acids
on the CDR3s of both chains (Figure 3.5).
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The presence of hotspots on the TCR has led to the idea that motifs can exist
within the CDR3s’ pair structural sequence [47][57]. Searching for these motifs
is a recurring theme in this thesis on the premise that by investigating these can
understand the TCR interaction mechanisms.
Despite cross-reactivity being a necessity for the immune system, this has also
been correlated to the induction of autoimmune diseases [19][56][57][58][61]. An
autoimmune disease occurs when the adaptive immune system recognises as “non-
self” an epitope that actually belongs to the host.
3.9 Public and private sequences
Another important phenomenon observed among TCR repertoires is the presence
of shared (or “public”) sequences among many individuals of the same population,
while other TCRs are unique to single individuals (“private”) [41].
The frequency with which private sequences appears is not correlated with the
relative abundance within the populations. Indeed, widely spread sequences in a
population can simultaneously be rare in each individual. However, it has been
seen that identical clonotypes present in more individuals often respond to the same
pMHC antigen epitope [63].
The causes of the presence of public sequences are not very well understood.
And it is not clear if there are evolutionary advantages to this phenomenon. How-
ever, we do know that the presence of public or private sequences is not influenced
by the environment, but is largely determined by the characteristics of the naı¨ve
repertoire [64].
The uniqueness of the TCR sequences can be explained by the propensity of
the V(D)J recombination to develop a TCR repertoire that is as variable as possible,
while the causes of the shared sequences are harder to uncover. In the literature,
two models have been proposed: the recombinational biases and convergent recom-
bination [63][65][66].
The recombinational biases consider that V(D)J recombination is not totally
random, and that some combinations of regions are preferred to others. Considering
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the V(D)J recombination as a pseudo-random event, therefore, means that over time
the same sequences are more likely to be present, and consequently to be shared.
Figure 3.6: Convergent recombination: Picture originated by [65] (Figure 1). In this
paper the authors investigated the role of public TCR in the population.
They explain it as coused by the convergent recombinational in which multi-
ple recombination events “converge” to produce the same nucleotide sequence
and/or multiple nucleotide sequences encode the same amino acid sequence.
Indeed, we can see this from the above picture, where multiple recombination
mechanisms (sub-fig. B) can produce equal nucleotide sequence and small
difference can still produce the same CDR3 (sub-fig. A).
Multiple rearrangements can converge to produce different nucleotide se-
quences, but these nucleotide sequences converge to encode the same amino acid
sequences [63]. In other words, the redundancy of the nucleotide triplets encoding
the same amino acid is considered to be one of the leading forces in the production
of sharing sequences [41][64]. In Figure 3.6 (source [65]), it is seen how equal se-
quences of CDR3 are originated by different nucleotide sequences, showing how the
convergent recombination provides the mechanistic basis for public TCR between
individuals [67].
These two models will be useful later in this thesis, when we will analyse the
common features expressed by the CDR3s.
The concept of private/unique sequences can be also applied to the CDR3 se-
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quences. Because in this thesis I am focusing on CDR3 β sequences, future refer-





Quantitative analysis of the CDR3
dataset
4.1 Overview of the repertoires
The CDR3 database derives from two experiments with a similar protocol per-
formed by Professor Friedman and colleagues in the Department of Immunol-
ogy, Weizmann Institute, Rehovot, Israel. The sequence files are available at
http://www.ncbi.nlm.nih.gov/sra/?term=SRP075893.
A total of 37 different C57BL/6 mice were sacrificed at different time points, of
which 28 were immunised with one or two different antigens, while the remaining
nine were left unimmunised and used as the control group. Details of immunisation
are present in [68] and also in [16] [69].
The C57BL/6 mice also known as “C57 black 6”, “C57” or “Black 6”, is one
of the most common inbred strain of laboratory rodent [70]. These are common
in different areas of research including cardiovascular biology, developmental biol-
ogy, diabetes and obesity, genetics, immunology, neurobiology, and sensorineural
research [71]. Within inbred strains of mice like C57BL/6, all individuals of the
line are nearly genetically equal to each other.
This is a great advantage for our experiment because we can test the effect
of different antigens on “copies” of the same mouse, with the assumption that the
different responses would not be affected by genetic factors.
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All 28 immunised mice were immunised with freeze-dried Mycobacterium
tuberculosis H37RA in water/oil emulsion, named Complete Freund’s Adjuvant
(CFA). Of these 28, 15 were also immunised in combination with another anti-
gen, ovalbumin (OVA) [72]. For this experiments the peptide used from ovalbumin
was “OVA 323-339” ISQAVHAAHAEINEAGR.
Freund’s Adjuvant (named after Jules T. Freund) is a solution of antigen emul-
sified in mineral oil. It exists in two forms, complete and incomplete. The com-
plete form is composed of heat-killed and dried Mycobacterium tuberculosis in
non-metabolizable oils (paraffin oil and mannide monooleate), whereas the incom-
plete form (IFA or FIA) lacks the mycobacterial components (hence just the water
in oil emulsion) [72][73].
Ovalbumin (OVA) is the main protein found in egg white, making up 54%
of the total protein content. Ovalbumin and albumin were some of the very first
proteins to be studied, the first crystallization of OVA having been recorded in 1890
[74]. The ovalbumin protein of chickens consists of 385 amino acids, and its relative
molecular mass is 45 kDa [75].
Of the entire database of 37 mice CDR3 repertoires, 24 mice come from a first
experiment composed as follows: six immunised mice were sacrificed five days
after the infection event, six immunised were sacrificed at day 14 and finally six
immunised and were sacrificed at day 60, with six unimmunised mice as a control.
For each time point group of mice, half were immunised with only CFA and the
other half with CFA plus OVA.
The second experiment involved: five mice sacrificed at day 7 and five mice
sacrificed at day 60. For each time point, three mice were immunised with CFA
plus OVA and two with only CFA, plus three unimmunized mice, for a total of 13
mice.
From all the mice, the spleen was isolated, and the TCR β chain from CD4+
T cells sequenced and then analysed with the software Decombinator [76]. De-
combinator is a five-item identifier that uniquely and unambiguously identifies any
Illumina short-read sequence data for individual TCRs, identifying their regions and
4.1. Overview of the repertoires 50
CDR3s.
In summary, our CDR3 database is composed of sequences from 37 different
mice.
1. Nine control mice, of which: six from the first experiment (1st) and three from
the second (2nd).
2. Six day 5 (1st), of which: three CFAs, three CFA+OVAs.
3. Five day 7 (2nd), of which: two CFAs, three CFA+OVAs.
4. Six day 14 (1st), of which: three CFAs, three CFA+OVAs.
5. Eleven day 60, of which: six (1st), five (2nd), five CFAs, six CFA+OVAs.
For a total of nine controls, thirteen mice sacrificed at an “early” stage, and
eleven at a “late” stage. Thirteen immunised with only CFA, fifteen with CFA plus










60 3 3 2 2
Table 4.1: The CDR3 repertoire database used in this thesis. 37 mice have been sac-
rificed and here is reported their distribution according to the antigen used and
the time they have been sacrificed. From left to right: There are 9 control mice
(6+3), 6 from Day 5, 5 Day 7, 6 Day 14, 11 Day 60. Of which 13 immunised
with CFA, 15 with CFA+OVA. Abbreviations: CFA = Complete Freund’s Adju-
vant; OVA = Ovalbumin.
Information about the sequencing procedure are present in [68] and its Supple-
mentary Material. Extensive pre-processing and error correction analysis of the raw
reads can be found in [77].
4.2. Terminology Adopted 51
4.2 Terminology Adopted
In this thesis are the reports of many different experiments performed with different
combinations of mice repertoire, based on the time they were sacrificed, or on the
antigen they were immunised with.
The repertoires from the first experiment are referred to as “Group A”, while
the second group of mice are called “Group B”. The mice immunised with CFA are
referred as CFA mice. The mice immunised with CFA plus OVA are referred to
simply as OVA.
4.3 Analysis of repertoires
In the following sections, there is an analysis of and a discussion about the CDR3
database used in this thesis concerning its principal features. These include number
and length of sequences, and compositions of the different mice repertoire. Because
all of the experiments were performed on this database, I considered it worth spend-
ing some time thoroughly exploring its features, evaluating it, and comparing our
findings with what it is reported in the literature.
4.3.1 Number of sequences
As I stated in the introduction, the number of sequences present in the body is one
of the main subjects of discussion in the literature regarding T-cell and CDR3 reper-
toire. Here, I compare my findings with what is present in the literature regarding
CDR3 in murine peripheral blood.
4.3.1.1 Total number of sequences
The total number of sequences in our database is 8 · 107, with a mean value of
2.1 ·106 and standard deviation of 2.6 ·106.
From Figure 4.1 and Table 4.2 we can also see that the values can vary from
different mice.
In general, we can see that the average number of sequences per repertoire from
the mice from the second experiment outnumbered 10-fold the number of sequences
from the first experiment.
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Figure 4.1: Number of unique sequences per mouse group: This box plot graph shows
the different presence of sequences with each group of mice. As we can see
the number of sequences can vary greatly, from half a million of control 1 (C1)
to several millions of Day 7 (D7). In general, it is considered that a value of
one million sequences or higher can give a good representation of the internal
variability of the mice of origin [36]. In our case we have a low number of
sequences for C1 and M2 1. These might not be considered enough for a good
representation of the mice CDR3 repertoire. Legend: C1 = Sequence from
Control mice from the first experiment; C2=Control mice second experiment;
D5= Day 5; D7= Day 7; D14= Day 14; M2 1= Two months, first experiment;
M2 2= Two months, second experiment.
Indeed, despite the first experiment having more mice, the actual number of
sequences is 2-fold lower: in the first experiment are present 2.1 ·107 sequences, in
the second experiment 5.9 ·107.
The number of sequences per mouse is shown in Figure 4.2 and Figure 4.3.
In Figure 4.2, each bar represents the number of sequences present in each mouse,
while the colour represents whether the mouse repertoire comes from the first or
second experiment.
From Figure 4.3, we can see the number of total sequences among the mice,
coloured per the antigen infection. The total number of sequences for the control
mice is 5.2 ·106, for the OVAs 4.3 ·107 and CFAs 3.2 ·107.
From the previous figures and tables, it is clear that the sequence originating
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Whole C1 C2 D5 D7
Mean 2.1 ·106 3.4 ·105 1 ·106 1 ·106 7 ·106
SD 2.6 ·106 2.5 ·105 7.5 ·105 6.8 ·105 3.4 ·106
D14 M2 1 M2 1 1st 2nd
Mean 1 ·106 3.9 ·105 4.1 ·106 8.9 ·105 4.5 ·106
SD 3.2 ·106 1.3 ·105 1.7 ·106 6.6 ·105 3.3 ·106
Table 4.2: Number of CDR3 sequences per group of mice: Summary table of the mean
and standard deviation of sequences present in all mice per mice groups and
per experiment-origin. From this table we can see that the amount of sequences
present in the entire database (Whole) can vary by one order of magnitude de-
pending from which time point the mice originate. We can see that from the sec-
ond experiment we have a higher number of sequences while from the first this
value drops to few hundred thousand of sequences. Label: Mean: Average value;
SD; Standard deviation. Groups legend: Whole = The entire CDR3 database; C1
= Sequence from Control mice from the first experiment; C2=Control mice sec-
ond experiment; D5= Day 5; D7= Day 7; D14= Day 14; M2 1= Two months,
first experiment; M2 2= Two months, second experiment; 1st= All sequence
from the first experiment; 2nd= All sequence from the second experiment.
from the second experiment is disproportionate. This is not an ideal scenario, but it
can be solved by applying various methods of normalisation and standardisation.
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Figure 4.2: Amount of sequences per mice by origin: With this plot, I represent the great
numerical difference between the number of sequences from the two different
experiments. The second experiment has almost the same amount of sequences
as all the mice from the first, despite fewer mouse repertoires. This gives an
unbalanced representation for the two sets of mice. Interestingly, the amount of
control sequences from the second experiment are much lower, increasing the
overall amount of control sequences, but not by much. Legend: 1st= Sequences
from the first experiment; 2nd= All sequence from the second experiment. On
the x-axis all the mice of the database, labelled: C1 = Control mice from the
first experiment; C2=Control mice second experiment; D5= Day 5; D7= Day
7; D14= Day 14; M2 1= Two months, first experiment; M2 2= Two months,
second experiment. y-axis= Number of sequences.
Figure 4.3: Amunt of sequences per mice per antigen: In this plot, similar to Figure 4.2,
I represent the number of sequences per mouse in relation to the antigen used
in the immunisation. Here the number of OVAs and CFAs sequences are more
balanced, and the two datasets are more alike with the number of OVAs of 4.3 ·
107 and CFAs 3.2 ·107. Groups as in Figure 4.2. Legend: Control=the control
mice; OVA = Mice immunised with the Ovalbumin; CFA = Mice immunised
with the Complete Freund’s Adjuvant. x-axis and y-axis: as in Figure 4.2.
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4.3.1.2 Number of unique sequences
In this section, we want to focus instead not on the total number of sequences, but
on the number of unique sequences.
In Table 4.3, Figure 4.4 and Figure 4.5, the value of unique sequences per
mouse, by group of mice are shown.
We can still see that the sequences are disproportionate, but the level of dispro-
portion is less pronounced, and the average values are in line with the literature.
Whole C1 C2 D5 D7
Mean 2.4 ·105 8.2 ·104 2.1 ·105 3.2 ·105 3.9 ·105
SD 1.4 ·105 5.1 ·104 4.6 ·104 1.4 ·105 1 ·105
D14 M2 1 M2 1 1st 2nd
Mean 2.6 ·105 1 ·105 3.5 ·105 1.9 ·105 3.3 ·105
SD 5.4 ·104 2.2 ·104 1.3 ·105 1.3 ·105 1.2 ·105
Table 4.3: Number of unique CDR3 sequences per groups of mice: Mean and standard
deviation of the unique sequences present in all mice, per different mice group
and per experiment-origin. This table is similar to Table 4.2, but while in Table
4.2 we saw a great variation in the total number of sequences, here the number
of unique sequences is more uniform with all values around 105. This implies
that a great number of sequences in the database are copies, and the number of
unique sequences is more uniform among our repertoires. Legend as in Table
4.2.
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Figure 4.4: Number of sequences for each CD R3 repertoire: Here, I represent the num-
ber of total sequences (lighter colour bars) side by side with the number of
unique ones (darker colour) in a y-axis log scale. We can see that the number of
sequences varies profoundly from mouse to mouse, while the unique sequences
are more balanced. Groups colour coding explained in the legend inset in the
top left corner.
In Figure 4.4 the value per mouse is presented, with the total number of se-
quences and the number of unique ones. We can see that the variation is smaller,
and all mice tend to have a more similar number of sequences.
In Figure 4.6, the size of the repertoire versus the unique sequences is plotted.
As we can see, an increase in the number of sequences is related to a higher number
of unique sequences, until they reach a plateau. To reach such a plateau at least a
million of such sequences is required, as already claimed in [36]. After this value,
the number of unique sequences grows much more slowly.
4.3. Analysis of repertoires 57
Figure 4.5: Amount of unique sequences and percentage per mice group: In the left-
hand side box plot are reported the of unique sequences present in all mice. We
can see that the number of sequences can vary greatly from group to group,
from few hundred thousand in C1 to several million in D7 or M2 2. How-
ever, the percentage of unique sequences is alike in all repertoires as reported
on the right-side box plot. In detail: the mean of the percentage of unique se-
quences is C1=4.3%, C2=4.6%, D14=5%, D5=17.3%, D7=4.5%, M2 1=3.8%,
M2 2=12.6%. Groups legend as in Figure 4.1.
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Figure 4.6: Size of repertoires versus number of unique sequences: From the analysis
of the repertoires we noticed that the percentage of unique sequences does not
vary greatly, and (except for D7 and M2 2) it is around 4-5% of the overall
sequenced. To better illustrate this behaviour, I created the above plot: from
each mouse, I take a fix number of sequences, and I check the progression of
unique sequences versus the total number, and I repeat it until the end of the
repertoire. With this system we can see the increase of unique sequences at the
increase of the repertoire. The number of unique sequences (y-axis) grows fast
until reaching a plateau of half a million sequences when the repertoire size
reaches 1-2 million of sequences (x-axis). Groups colour coding explained in
the legend inset in the bottom right corner.
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4.3.2 Length of CDR3 sequence
The average length of the entire CDR3 dataset is 16.31 (see Figure 4.7), with a
variance of 3.55 and a standard deviation of 1.88.
In Table 4.4 the percentage of sequences with the most abundant length is
reported.
Length ≤ 14 15 16 17 18 ≥19
Percentage 11.15 13.85 23.31 27.88 17.21 6.6
82.25
Table 4.4: Percentage of sequences length: Percentage of the most abundant sequence
lengths expressed in nucleotides (nt). In this table, I report the distribution of
CDR3 sequence length. We can see that the 82% of all sequences are distributed
in four values from 15 to 18 nt, with the relative majority (median) of sequences
having length 17 nt, but a mean value of 16.31 nt (not reported in the table).
Results are consistent with many other works [6][78][79][80][81][82][83].
Figure 4.7: Distribution of lengths of CDR3 repertoires: In this graph is reported the
distribution of sequences’ length through the database. The distribution is a thin
bell shape with practically all sequences inside one standard deviation far from
the mean. The central dotted line is the mean of all length of sequences (16.31),
and the side lines are one standard deviation. Also, the overall distribution is
left-skewed (Negative Skewness) with mode and median equal to 17. Groups
colour coding explained in the legend inset in the right hand side.
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4.3.3 Jaccard index
The Jaccard index (JI) [84] is a coefficient measuring similarity of finite sample
sets. It is defined as the size of the intersection divided by the size of the union of
the sets, see Equation 4.1:
J (A,B) =
|A⋂B|
|A⋃B| ; 0≥ J(A,B)≥ 1 (4.1)
The JI ranges from 0 to 1, in which the higher the value, the more similar the
two sample sets.
This formula computes the similarity among repertoires. The dissimilarity be-
tween the sample sets (also known as Jaccard distance) is the complementary of the
JI.
In this case, I computed the proportion of shared sequences among all mice.
This is reported in Figure 4.8.
All the results are consistently low, not higher than 0.268, and with an average
value of 0.135.
We could expect that nearly genetically identical mice, immunised with the
same antigen would develop similar immune repertoires. But if we look at the JI
per antigen, the results are still low: JI per Controls is: 0.126; OVAs: 0.137; CFAs:
0.139.
Therefore, as already claimed in [16] and [77] the immunization event alters
the repertoire states, but it does not drive a repertoire convergence.
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Figure 4.8: Heat-map of the Jaccard index of all repertoires: In this heat-map plot I
represented the JI of each mouse against everyone else. The JI is a measure of
similarity between repertoires and with this plot we can actually see that: 1) the
group Control 1 has the lowest average JI against all other groups. However,
this characteristic is not present in the Control 2 group. 2) The highest values
are between the group D5-D14 and D7-D60 2. In theory these groups should
have very little in common and worryingly the only thing that they share is
the experiment of origin (second experiment). 3) Low values also for D60
and D60 2, while we would have expected high values, considering the same
type of experiment and time point. The diagonal values (identity values) are
excluded. Blue, green and yellow indicate progressively higher Jaccard index,
i.e. higher dissimilarity between sample pairs.
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4.3.4 Gini coefficient
The Gini coefficient [85] is a measure of statistical dispersion of a frequency dis-
tribution. The value of the Gini coefficient falls within a range between 0 and 1,
where 1 is a perfect inequality and 0 is a uniform distribution. It is used primarily
to study population, in multiple fields from economics to immunology [86].

















In Equation 4.2 the numerator is composed of the sum of the absolute value of
the difference of all elements x of a set X . The denominator is the sum of X times
double the number of elements in X .
Figure 4.9: Graphical representation of the Gini coefficient: In this graph, we can see
that the cumulative share of population creates a line in red, called the Lorenz
Curve. Such a curve can only be equal to or lower than the uniform distribution
line in blue. The further the Lorenz curve is from the uniform distribution line,
the lower the Gini coefficient. The Gini coefficient can be also computed as
A/(A+B). The area A is the area between the uniform distribution line and the
Lorenz curve. B is the area under the uniform distribution line minus the area
A.
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Let us take for example a population in which the percentage of total wealth is
distributed as follows: 2% of wealth for the poorest 10%, 18% for the 40%, 30% for
another 40%, and 50% for the remaining richest 10%. The Gini Coefficient applied
Equation 4.2 would be 0.25. This low value is not a surprise considering that half
of all the wealth belongs to 10% of the population.
A representation of this example is in Figure 4.9: we can see that the Gini
coefficient can be also computed as the difference of the area between the uniform
distribution line and Lorenz curve and all the area under the uniform distribution
line.




For A = 0 the Lorenz Curve is equal to the uniform distribution line.
My aim with this coefficient is to see if, in each mouse repertoire, there are
sequences with a high frequency, with the assumption that an over-represented se-
quence might be relevant to the immune response.
I computed the coefficient using the R package ineq.
The average Gini coefficient of our repertoires is 0.65, with a standard devia-
tion of 0.08. This means that there is a small number of sequences with a very high
frequency. However, the number is not overwhelming. Moreover, the Gini coeffi-
cients of the control groups are no different from the immunised mice. Therefore,
we can claim that the immunisation event is not a driving force pushing the immune
response towards an over-representation of one or a few sequences.
In Figure 4.10 the Lorenz Curve for all mice is reported, coloured according to
their group. Each line is somewhat far from the uniform distribution line, indicating
a high Gini Coefficient value as a result. Indeed, if we look at the bottom green line,
this mouse is a D7 mouse and in Figure 4.10 we see the same outline in Group D7
(yellow).
From Figure 4.10 it is possible to regard the Gini Coefficient value represented
as a box plot for all mice groups. We can see that all repertoires have a dissimilar
value, which could vary greatly. Look at example groups D60, in which the first
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Figure 4.10: Gini coefficient of our repertoires: Left-side plot: Box plot for the Gini coef-
ficient of our repertoires. In the plot each group of mice is reported in a differ-
ent colour, the dash line being the mean Gini value of all repertoires together.
We can see that the value is not constant, and it can change greatly. Right-side
plot: Lorenz curve of our repertoires: here is represented the Lorenz curve
for all our repertoires. Each line represents a different mouse and is coloured
according to its group. All curves are far from the uniform distribution line,
varying and reflecting the Gini coefficient. High Gini coefficient value, as for
D7 and Day60 2, do not imply a low level of variability but rather that a few
numbers of sequences are overrepresented. It is not easy to determine if such
overrepresentation is due to an issue in the sampling or sequencing process,
or of an effective relevance in the mice immune response prior to the sample
collection.
group has a level around 0.55 and the second around 0.75. It is hard to figure out
the cause for this discrepancy.
Indeed, it seems that the Gini Coefficient is higher when the repertoires are
bigger. This is confirmed by the following plot, where the Gini coefficient is put in
relation to the repertoire size.
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Figure 4.11: Gini coefficient in relation to repertoire size: With this plot I assessed if
the Gini coefficient value is related to the size of each repertoire. We can
see that the bigger the repertoire, the higher is the Gini coefficient. Because
the number of unique sequences stop growing after one million of sequences,
while the Gini coefficient keeps growing with the size of the repertoire, is my
understanding that the high Gini value is not due to an overrepresentation of
sequences inside the mice but to errors in the analysis process.
In Figure 4.11, we can see that the Gini coefficient value grows with the amount
of sequences. Theoretically, the Gini coefficient should not change in relation to the
amount of sequences sequenced. The sequencing process should give us the same
percentage of type of sequences: for 1,000 or 1 million sequences we should have
approximately the same value.
This is due to a few sequences with a lot of replication in those repertoires,
probably caused by technical problems in the library production.
Support Vector Machines as






Support Vector Machine (SVM) is a supervised learning model [87] used for data
classification and regression analysis. It is one of the main machine learning meth-
ods used in modern day artificial intelligence, and it has spread widely in many
fields of research, not least in bioinformatics.
SVM can be used for regression and classification analysis. In this section, I
will describe and show the use of the latter.
Programming languages like R or Python offer several libraries to compute
and work with SVMs in a simple and flexible way. For these reasons, SVM is the
principal classification method used in this thesis, and for the first two years of my
PhD my projects and tests revolved around this method.
At the beginning of the first year of my doctorate, I started working on the
research made by N. Thomas and presented in the paper [16] and in his thesis [88].
My initial task was to repeat his work, continue the investigation on triplets, and
extend the classification to other CDR3 repertoires. Given the interesting results
arising from this work, this soon became my main task, and the objective of the
thesis you are now reading.
The application of SVM for the classification of CDR3 is not an immediate
action, and its application required a series of steps. The prime issue is that the
CDR3 repertoires are composed of strings of letters: therefore, we need to have
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converted them into a suitable numerical format.
To make it possible, in [16] four different bioinformatics methods are used,
those being:
1. The bag of words and k-mers: we create all possible combinations of amino
acids of different length, such as duplets (2-mers) and triplets (3-mers), and
by counting their presence within the repertoire we form a codeword for that
repertoire.
2. Numerical factors with this, we convert the codeword into numerical vectors
and with
3. k-means algorithm we gather them in a numerically smaller number of fea-
tures.
4. And finally, the Support Vector Machine for the classification of CDR3
repertoire.
In this section I present my work with the core ideas in [16], my results, the
pros and cons of the methods, and the extension of these to new repertories. Be-
fore describing my findings, however, it is worth providing an introduction to these
methods, starting from the most important, the SVM, and proceeding with the oth-
ers.
5.2 Support Vector Machine
5.2.1 History
The idea behind the Support Vector Machines (SVM) is to be able to find a sepa-
rating line between two classes of elements as points in space. This concept was
proposed and designed by Vapnik and Lerner in 1963 [89], wherein the idea of
maximum-margin hyperplanes was first introduced.
The method was further developed over the following 30 years by Vapnik and
other researchers, gaining greater consideration during the conference COLT 1992
[90]. The modern day SVM method was completed in the following five years, with
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the application of the kernel trick to find the maximum margin hyperplane for the
nonlinear separable space and the implementation of the soft margin in [91], later
improved with [92][93][94].
5.2.2 Introduction
As mentioned in the previous section of this thesis, the SVM is a type of supervised
machine learning, meaning the method needs a training set of labelled elements that
will be used as a reference for assigning the class of unknown elements.
A supervised machine learning method needs to be “trained”, and it goes with-
out saying that the better the training set, the more accurate its prediction. The
action of prediction means to assign a new, unknown element from what is called
the test set to one of two classes, performing a binary classification.
In action, what the SVM really does is provide the optimal dividing line (or
hyperplane) between the two classes of elements, mapped into an n-dimensional
space (or hyperspace).
Any class of items, be they a house, a car, or a repertoire of CDR3 sequences,
possess some set of features that can be sorted and measured. If we consider each
feature as a dimension in a coordinate system, and the measures as coordinates, we
can represent any item of our class as points in an n-dimensional space.
The optimal hyperplane is defined as the hyperplane most separating from the
two classes: after it is found, it is possible to identify the class to whom a new
element corresponds [95][96].
In summary, the SVMs can learn a decision function or hyperplane from a
training set of examples (input) and perform a binary class recognition (output) of
a new element or test set, using a non-probabilistic classification in a high dimen-
sional feature space or hyperspace [97].
5.3 SVM: the concept
Let us consider two sets of elements with only two features.
For these examples, I choose to plot the data “iris” from R, for the flower type
“setosa” and “versicolor”.
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Figure 5.1: Example of two sets of data in two dimensions: Here are reported two species
of the Iris flower data set, Setosa and Versicolor, plotted in relation to their
length and the width of the petal. A large gap is present between the two groups
and we can intuitively consider them as part of two groups.
The data are reported in Figure 5.1. We have got two different sets of flowers
in relation to the length and width of their petals.
As you can see, there is a large gap of empty space between the two sets of
data. We could easily draw an arbitrary line between the two sets and divide the
space in two.
Now, in Figure 5.2, the plane is divided in two. Everything that is, or will be,
present above the line would be classified as “versicolor”, everything below the line
as “setosa”. Using this setup, we can easily classify the elements just by looking at
where they would lie in the space.
The space between the points is called hyperspace, and the dividing line is a
hyperplane. The hyperspace can be formed by any number of dimensions n, while
the hyperplane has always one dimension less n−1. If the hyperspace is a line, the
hyperplane would be a dot; for a plane, it would be a line (as for our example); for
a 3D space, it would be a plane, and so on.
In Figure 5.2, we have now got a hyperplane between the two sets. However,
this is not the only possible solution. In fact, an infinite number of hyperplanes can
be drawn, as we can see in Figure 5.3.
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Figure 5.2: Arbitrary dividing line between two sets of data: As mentioned, we can
intuitively divide the flowers into two distinct groups and we can choose to
draw a separation line between them, aiming to divide the space between them
into two equal spaces, so maximising the distance between the points and the
line.
Figure 5.3: Infinite number of hyperplanes between two sets of data: The number of
valid hyperplanes that can be drawn in a hyperspace is infinite. Any line, with
any angulation and distance to the points counts as a hyperplane as long as the
two set of points are in different hyperspaces.
An infinite number of lines are therefore possible, but we need only one of
them, and possibly one that would give less misclassification and a better perfor-
mance of any future prediction.
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Therefore, which one is the best line? And how can we find it?
The answer to the first question is: the optimal hyperplane is defined by the
maximum margin of separation between any training point and the hyperplane [96].
Therefore, among all infinite possible hyperplanes between two sets (Figure
5.4 A), the optimal hyperplane is the one with the highest distance to the margins
(Figure 5.4 B).
Figure 5.4: Examples of possible hyperplane: In sub-fig. A it is represented a selection
of possible hyperplanes where their margins have been highlighted. From the
vertical margins (light yellow) to the horizontal (light red), the possible hyper-
planes are infinite. However, the optimal one has the largest margin between
the points. In sub-fig. B I report the optimal hyperplane for this set of points.
This is the hyperplane with the largest distance between the two margins, inter-
acting only with the most external point of the classes, called the hard margin,
in contraposition to the soft margin which we will see later.
Because the optimal hyperplane would be defined by its distance to the mar-
gins, and not by all data points, usually a small set of data points is enough to find
the optimal hyperplane, as we can see in Figure 5.4. These relevant data points are
referred to as support vectors.
As to the how, the answer is more complex, and we need to introduce some
mathematics to this explanation.
5.3.1 Finding the best hyperplane
In our example, we have used two-dimensional data: length vs. width of flower
petals. Because the hyperspace is two dimensional, the hyperplane must be a line.
5.3. SVM: the concept 73
The formula of a line is: y = ax+ b, and this formula is not dissimilar to the
general formula of the hyperplane, that is defined as:
wtx = 0 (5.1)
The left-hand side of Equation 5.1 can be considered as the inner product of
two vectors. Indeed, when we are dealing with points in space, as in this case, it is
useful to use the concept of vectors.
The introduction of the concept of vectors should not be a surprise, given the
name of the subject. However, explaining the entire vector algebra and the mathe-
matics would be needlessly long, and in this thesis, I am giving a minimal amount
of information in order to understand the concept:
A vector is defined as any quantity with a magnitude and a direction.
In other words, a vector exists between the origin O(0,0) and a point in the
space.
The magnitude of a vector, x, is its length. This is usually written as ‖x‖ and
called the norm of the vector. For the point P(3,4), the distance from O(0,0) can
be computed with Pythagoras’ theorem and would be 5.








In our case ‖P‖= 5 therefore, the vector W (35 , 45) =W (0.6,0.8).
Using the definition of vector and the vector algebra we can measure the dis-
tance between our points and the origin, and from this compute the hyperplane.
When the two classes are linearly separable, it is possible to find two parallel
hyperplanes with the distance between them as large as possible. These two hy-
perplanes are in contact with the elements of the two classes and they are called
“margins”. These types of margins are called hard margins
Because these two hyperplanes define the maximum margin possible, the hy-
perplane that lies halfway between them would be the best hyperplane.
These hard margins can be described by the equations 5.2:




Consequently, we can write the hyperplane as wtx+b = 0.
Figure 5.5: Formulas of the hyperplane: Here are reported an example of hyperplane line
(black) alongside the two hard margins (red) and their formulas. The optimal
hyperplane is the one with the highest distance between the margins, therefore
the distance between the two margins and the hyperplane is the same (±1) and
the distance between the two margins is 2‖w‖ .
The result is reported in Figure 5.5. There we have the hard margins in red and
the hyperplane in black. Therefore, the best hyperplane is the one with the maximal
distance m to the margins.
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To maximize the distance from the margins, we must minimize ‖w‖.
If we add the constraint that no points should be present between the margins,
we can rewrite Equation 5.2 as Equation 5.6:
wT x+b ≥ 1 when y = 1
wT x+b ≤ 1 when y =−1
rewritten as yi (wT x+b)≥ 1, ∀ i f or y =±1 (5.6)
We can conclude saying that the best decision boundary would found by solv-
ing the following constrained optimization problem, Equation 5.7:
max 2‖w‖
sub ject to yi(wT x+b)≥ 1
(5.7)
Coming back to our example seen in Figure 5.4, I isolate two possible hyper-
planes, as reported in Figure 5.6:
In the case reported in Figure 5.6, the optimal hyperplane is the one on
the right-hand side. Indeed, if we compute the distance between the hyper-





, the result is 1.03 for the left-hand side and 1.07 for the one
on the right.
5.3.2 Soft Margin
The biggest limitation of this approach is that the method does not consider potential
error due to outliers. In the previous example, a single outlier too close to the other
class would have biased the margins. In addition, it is not always possible to find a
clear line between two sets of points. For example, as we can see in Figure 5.7, it is
not possible to draw a line that divides the two sets of data without assigning data
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Figure 5.6: Example of two possible hyperplanes: Here two different hyperplane lines
(black) and their margins (red) are reported. Also present is the formula of
the line that they represent. Because in this example we work only with two
dimensions, we can work out the distance between the margins and compute
the optimal hyperplane. The distance between the margins of the left-hand side
plot is 1.03 and on the right-hand side it is 1.07, therefore we can decree that
the optimal hyperplane for this set of data is the one on the right-hand side.
points in the wrong hyperspace.
Figure 5.7: A non-linearly separable set of data points: In this plot I report another
subset of the iris dataset, the group Versicolor and Virginica. Once plotted it
is clear that is not possible to find a straight line that would separate the sets
without leaving some points in the wrong side of the hyperplane.
For these reasons, these kinds of margin are called hard margins. To solve this
problem, the concept of the soft margin has been introduced [98].
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In order to find a soft margin for a linear kernel we have to introduce the hinge
function: max(0,1− yi (~w ·~xi−b)), of which yi is the target and, (~w ·~xi−b) the
value of the theoretical repertoire is the result. The function returns zero if the








max(0,1− yi (~w ·~xi−b))
]
+λ ‖~w‖2 (5.8)
Where the parameter λ is the trade-off parameters between increasing the margin
and misclassified points.
Figure 5.8: A hyperplane in a non-linear separable space: In this plot a possible linear
hyperplane for this set of data is reported, using a soft margin approach. With
the soft margin approach, misclassified points are weighed and computed to
produce a hyperplane with the lowest value of misclassification.
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5.3.3 Nonlinear classification: the Kernel trick
So far, our example has used a version of SVM that uses the dot product between the
vectors to compute the maximum-margin hyperplanes, but in [98] a way to create
nonlinear classifier by applying the concept of the kernel trick was introduced [99].






sub ject to : yi (wtx+b)≥ 1−ζi with ζi > 0
(5.9)
In which, the slack variable ζi = max(0,1− yi (~w ·~xi−b)) for each i ∈
{1, ... ,n}.
The variable ζ introduces a penalty for misclassified values. The optimal mar-
gins would be computed using a trade-off between the misclassifications and margin
width. It defines how far the influence of a single training point reaches, in other
words how many points far from the decision boundary are considered by the func-
tion. If it has a low value it means that an example has a far reach, close otherwise.
C is the regularisation parameter of the error term that controls the trade-off
between maximizing the margin and minimizing the training error. Small C tends
to ignore the outliers, while large C may tend to overfit the training data. These two
parameters are not known a priori and one of the most common methods for tuning
them is a combination of cross-validation and grid-search.
In the kernel trick each dot product is replaced by a nonlinear kernel function.
This transforms the feature space, increasing the number of dimensions. One of the







−γ ∥∥~xi−~x j∥∥2) f or γ > 0 (5.10)
In Figure 5.9, we can see that the first set of elements are points on a line
(Figure 5.9 A) in which the two classes are clearly overlapping, so we increase
the dimension to two (Figure 5.9 B). However, there is still too much overlap. By
increasing once again to three dimensions, we can finally divide the classes (Figure
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5.9 C).
Figure 5.9: Increasing dimensions to find a separable space: In this plot I am giving
a visual representation of how increasing the number of dimensions of a data
set can help us to find a hyperplane that correctly predicts more and more data
points. In sub-figure A1 we have a set of one-dimensional data points. The
two classes of points red and blue are distributed on a line (the hyperspace) in
a way in which it is impossible to find a clear separation point, as we can see in
sub-figure A2 (the same data points of A1 but in a scatter form). However, if
we increase by one dimension as in sub-figure B, and we draw a hyperplane,
the number of mislabelled points decrease. This is even more the case if we
increase by another dimension as in sub-figure C. Here there are no misclassi-
fied points. In conclusion, by increasing the number of dimensions, it is easier
to find an optimal hyperplane that decreases the number of misclassified data
points.
Using the kernel trick, it is possible to find a non-linear hyperplane without
actually transforming the coordinates to a higher dimensional space.
The algorithm of the SVM is similar, but with the kernel trick every dot product
between vectors is replaced with a nonlinear kernel function.
5.3.4 Multiclass SVM
As I have shown, SVM is inherently a two-class classifier. The best hyperplane is
found between two classes and hence is optimal for binary classification problems.
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Nonetheless, SVM can be applied to multiclass classification problems by reducing
a multiclass problem to a series of binary-classification problems.
The most common strategies are the one-against-rest (OvR) and, the one-
against-one (OvO). The latter is used in this thesis, see [100].
In the first strategy, during the training phase, each class’s point is considered
as one class, while all the other points from all other classes, are considered as a
different class. In the testing phase, the samples are classified either as the single
class or as the one formed by all other classes.
In the second strategy, for each class is applied a K(K− 1)/2 binary classifi-
cation for a K-way multiclass problem. Each binary classification receives samples
from the training set of the pair of classes. During the testing phase, a voting system




The bag of words (BOW) is a strategy usually adopted when we need to convert a
document of strings, e.g., words in a book, into a vector of pure numbers that can
be used for any sort of mathematical evaluation.
At first, this method was used in text [101] and image classification [102], but
it has recently been introduced into bioinformatics, and can be successfully applied
to CDR3 sequences’ repertoires. For more general details of these approaches see
[103][104][105].
With the BOW approach, we can redefine a highly complex document, such as
a picture or a book, into a smaller set of low-level features, called codewords (also
a codebook, dictionary or vocabulary).
The quality and origin of features is arbitrary, i.e. if we want to analyse a
book or a series of books, we can choose as features all the words present inside the
books, or the letters, or the combination of letters. As for the origin, the features can
be all words present in the same books or all the words in the English dictionary, etc.
As a result, the length of a codebook is defined by the number of features chosen.
6.1 Bag of words: Example
Item 1: Tom likes to go to the cinema on Sunday.
Item 2: Martin likes to go to the cinema on Tuesday.
Item 3: George prefers to visit science museums.
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Item 4: Carl prefers to visit art museums.
First, we need to choose what type of feature we want to use. Because we are using
four short sentences, we can use all the words present in the whole document.
Therefore, our code word is a list of all the words in the document without
duplicates:
Codeword:
art, Carl, cinema, George, going, likes, Martin, museums, on, prefers, science,
Sunday, the, to, Tom, too, Tuesday, visit
We can now represent each sentence as a vector, see Table 6.1:
Codeword Item 1 Item 2 Item 3 Item 4
art 0 0 0 1
Carl 0 0 0 1
cinema 1 1 0 0
George 0 0 1 0
go 1 1 0 0
likes 1 1 0 0
Martin 0 1 0 0
museums 0 0 1 1
on 1 1 0 0
prefers 0 0 1 1
science 0 0 1 0
Sunday 1 0 0 0
the 1 1 0 0
to 2 2 1 1
Tom 1 0 0 0
Tuesday 0 1 0 0
visit 0 0 1 1
Table 6.1: Codeword for each sentence/item: In this table is represented each sentence as
vector. In the first column there is the codeword with all single words present in
the documents. In the following columns are listed the frequency of that word in
each sentence. As result each sentence is now turned into a vector of numbers,
in which any position of the vector represents a word and the numerical value its
frequency in the sentence.
At this point, we can use these numerical vectors for any type of mathematical
analysis.
For example, we can consider each vector as a point in an l-dimensional space,
where l is the length of the codebook.
6.2. Application to the CDR3 repertoires 83
We can measure the distance between any points using the Euclidian distance
[106]. In Table 6.2 we can see that items 1-2 and items 3-4 are closer to each other
than the other combinations.
Item 1 Item 2 Item 3
Item 2 2.0 - -
Item 3 3.6 3.6 -
Item 4 3.6 3.6 2.0
Table 6.2: Euclidean distance between items: In this table is represented the Euclidian
distance between each vector originated by Table 6.1. With this table we can see
that vectors which originated from sentences with more words in common have
a shorter distance.
6.2 Application to the CDR3 repertoires
The first problem we encounter when we apply the BOW model to the CDR3 reper-
toires is the choosing of the codeword features. If we use all elements of the CDR3
repertoires in the same way as we did for the example in the previous section, we
would have an incredibly long codeword. Indeed, for a normal repertoire of around
1 million CDR3s, we can find more the 40,000 unique sequences.
This would lead to a codeword of an extremely high number of dimensions,
posing several problems not just for the computational time required for its calcula-
tion, but also for the over-fitting issue that machine learning methods will incur.
The solution adopted here is to use all contiguous sub-strings of amino acids
present in the repertoires. This approach is called k-mers [107][108].
6.2.1 k-mers
By the term k-mer is indicated all possible sub-strings of length k that are contained
in a string. In our case we will refer to all possible sub-sequences of amino acids
(of length k) present in the CDR3. Namely, single amino acids for k = 1, duplets
for k = 2 and so on. k-mers are usually used for sequence analysis [109], motif
identifications [110] and genome assembly algorithms [108][111].
The number of all possible k-mers present will form the codebook size that
we will use. This size grows exponentially with the formula nk, wherenis the given
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possibilities and k is the length of the sub-string, i.e.: A sub-string of two amino
acids would have all the combinations of 20 amino acids, such as: AA, AC, AD
etc., for a total of 400 possible combinations.
Once we have chosen the size of our string, we divide our sequences into all
continuous subsets of that size. The number of k-mers for a given sequence of length
L is: L− k+ 1. In other words, for a string size of 2 and a sequence of 10 amino
acids we obtain 9 features, as from the first position of the sequence, we move our
string one position at a time, until we reach the penultimate amino acid.
6.2.1.1 Example:
The codewords will all be triplet combinations of 20 amino acids, for a total of
8,000 features:
AAA (1), AAC (2), AAD (3), ... , YYV (7998), YYW (7999), YYY (8,000)
The sequences will then be parsed as in Figure 7.3:
Figure 6.1: Continuous sub-strings of k-mer in a CDR3: In this plot I represented all
the continuous sub-strings of k-mer of length 3, referred as triplets, present in a
CDR3. On the top, is present an example of a CDR3 sequence: CASSLSGSF-
FGPG, we proceed from the left-hand side of the sequence and we select the
first sub-string of three amino acids (triplet), then, we slide one position to the
right, selecting all sub string until the end of the sequence. All continuous sub
string of triplets we select are listed below the sequence: CAS, ASS, etc. The
total number of sub-strings is given by L− k+ 1, where L is the length of the
string and k is the lenght of the sub-string, in this case the result is 11.
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We repeat this process for all the sequences, then we just need to count the
frequency of each triplet, the result being seen in Figure 6.2.
Figure 6.2: Count of all triplets in a CDR3 repertoire: In this plot I represent the CDR3
repertoire as a histogram with the frequency (y-axis) of each triplet (x-axis).
We can see that some triplets are overwhelmingly overrepresented while others
are almost if not totally absent.
Chapter 7
K-means
Using the bag of words and k-mers we are now able to convert our database of se-
quences into codewords formed by combinations of k-mers and their frequencies.
However, for k-mers where k is greater than 2 the size of the codeword grows expo-
nentially, and for triplets we already have 8,000 features. Such value has originally
been considered too large in [16]. Clustering together the most similar triplets has
been proposed as a way to reduce that number. It has been choosen to use the
partitional clustering method of k-means.
The k-means algorithm performs better as compared to a hierarchical algorithm
(HC) [112] and the execution takes less time, with a time complexity of O(n2) [113],
lower than other HC methods that have a time complexity between O(n3) [114] and
O(n2 logn). On the other hand, HC provides good quality results in respect to k-
means. In general, a k-means algorithm is good for a large dataset and HC is good
for small datasets [113].
7.1 The algorithm
Given a set of points, where each point is an n-dimensional vector, the algorithm is
able to separate the n points into k sets (with K ≤ n), forming a number of clusters
S = {S1,S2, ... ,Sk} with centers (µ1, ... ,µk), the Within-Cluster Sum of Squares
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The algorithm is composed of four steps:
1. Starting seeds: allocate randomly a k number of starting points named
“seeds”. After the first iteration, these points are called centroids. See Figure
7.1.
Figure 7.1: K-means algorithm, step 1: Three seeds are selected in a dataset space. Much
freedom is given to the seed choosing; they can be randomly selected point in
the space or following pre-determined formulas. Figure source [115]
2. Assignment step: Compute the distance between each of the points of the
experiment and the seeds. Usually the Euclidean distance is used. The point
considered closest to a seed is considered a part of that cluster. See Figure
7.2.
Figure 7.2: K-means algorithm, step 2: Once the seeds are chosen, the data points with
the smallest distance to one seed are considered as part of a newly formed
cluster. In the plot are formed three clusters, red, blue and green, covering all
the space closest to each respective seed. Figure source [115]
3. Update step: Calculate centroids: inside the newly formed cluster, a new
centroid is computed as the average points amongst all of the point forming
the cluster. If the new centroids have the same position as before, proceed to
the fourth step. If not, repeat the previous step. See Figure 7.3.
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Figure 7.3: K-means algorithm, step 3: Now that a first cluster is formed we proceed by
computing a new centroid for each cluster. If in the previous step the seeds
where randomly chosen, now the centroids are computed as the middle point
among all of each cluster. Figure source [115]
4. Exit step: When all centroids in the iteration i and in the previous iteration
i−1 are equal, the clustering process is completed. This is also known as the
convergence phase of k-means algorithm. See Figure 7.4
Figure 7.4: K-means algorithm, step 4: When the new centroids are computed the process
restarts: all data points are reassigned to the closest centroid, a new centroid is
computed and so on. The process exits when the position of all new centroids
is equal to the previous ones, as this means that the process has reached a stable
point and the data points will not be assigned to new clusters. Figure source
[115]
7.2 Limitations
The k-means algorithm is an unsupervised algorithm, meaning that it does not need
a training/test set. The algorithm is very sensitive to outliers and their presence can
skew the cluster formation or in extreme cases create clusters of single elements.
It is important to comment on the choice of the initial seeds: seeds are usually
chosen randomly and different runs of k-means on the same database could produce
different cluster results.
We can choose how many clusters we want in our output, but we cannot be sure
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if that is correct. Many methods have been proposed to compute the right number
of clusters, such as the elbow method or some rule of thumb such as: k ≈√n/2,
where n is number of points and k the optimal number of clusters. However, no
method is definitive.
An example is the set of data ”iris” used in the previous chapter. We have
three sets and 150 points. If we apply the rule of thumb k ≈√n/2, the result is√
150/2≈ 8. This result proves that also this method is inadequate to compute the
correct number of clusters.
In Figure 7.5. I applied the k-means algorithm, with three clusters, and also
with the correct number of cluster the final result has some minor errors.
Figure 7.5: Real case application of k-means algorithm: In this plot I apply the k-means
algorithm to the dataset used in the previous examples. On the left-hand side we
have the iris dataset coloured according to their real class and on the right-hand
side the data classified according to the k-means. The algorithm correctly di-




In this section, we are now going to examine the results for the application of the
SVM to the CDR3 repertoire classification problem. The section is composed of
my analysis and redoing of [16] and the application of SVM method to different
repertoires and the required new actions.
1 Bag of Word (BOW)
To get the n-dimensional point required for an SVM classification we first need to
‘convert’ our CDR3 sequence from strings to numerical vectors. We have already
seen how to apply the BOW and k-mer to the CDR3 sequences in section 6.2, and
that it is a clever and effective way to reduce the complexity of the repertoire, con-
verting a huge set of strings to a simple vector of numbers by reducing the “word”
of the BOW to single amino acids, duplets, triplets and so on.
Here, I have used duplets and triplets. These combinations of amino acids
are considered an optimal compromise between the use of single amino acids that
might lead to a loss of information, and the use of longer p-tuples, that would be
very computationally expensive and hard to compute.
2 K-means algorithm
As we have already seen, the k-means algorithm works with a point in space, and
we have only strings of letters (AA, AC; AAA, AAC, etc.). Somehow, we need
to convert these strings into numbers in order to have some suitable measure of
distance between points.
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Thus, any amino acid must be replaced by numbers. In [16] the Atchley nu-
merical factors are used. Let us see what they are.
3 Numerical factors
For each amino acid in the available literature there are tables of values listing
the different features of the element, such as polarity, hydrophobicity, etc [116].
Parallel to the studies of the single amino acids features, other authors have
focused their attention on what is called the “sequence metric problem” [117]. In
this, a great number of chemical/physical amino acid properties are gathered to-
gether, and each amino acid is given a synthetic and representative numerical value.
Converting the alphabetic letters into an array of numerical values allows us to sum-
marise all the underlying properties of each amino acid.
In my analysis, however, I have extended the work to three other numerical
factors, including two from the literature: the Sandberg [118] and Kidera [119],
and one to use as a control and without biological meaning. More details for each




In [117] the authors used multivariate statistical analyses to
reduce 494 amino acid attributes into a smaller set of highly
interpretable numeric patterns. These are summarised by five
multidimensional patterns of attributes that reflect polarity,
secondary structure, molecular volume, codnaon diversity and
the electrostatic charge of each amino acid.
Using an alphabetic letter code to represent the amino acid
would result in a loss of information on the physiochemical
properties of amino acids. For example, the amino acid leucine
(L) is more similar to valine (V) than leucine is to alanine (A).
However, the alphabetic “distance” between these letters in the
alphabet does not reflect these relationships. Therefore, the use
of the small set of numerical features that they propose, can
help to understand relations and similarities between different
amino acids.
Sandberg 5
In [118] the authors analyse 26 different amino acids, proper-
ties from 87 amino acids, and using the principal component




In [119] the author worked on 188 physical and conformational
properties of the 20-natural occurring amino acids in order to
reduce this number to a smaller value (10) without losing the
information contained in their physical properties. In the pa-
per they first use hierarchical cluster analysis to cluster similar
amino acid properties together before using partial correlation
factor analysis to produce a single numerical value for each
cluster. The result is 10 values, one for each of the following
properties:




5. Normalized frequency of double bend.
6. Average value of average composition.
7. Average relative fractional occurrence.
8. Normalized frequency of alpha-region.
9. pK-C
10. Surrounding hydrophobicity in β -structure.
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Arbitrary 20
Last, I used numerical factors without any relation to
any amino acid properties. I choose to use a vec-
tor of 20 numbers, with a single positive number cor-
responding to the alphabetic order of the amino acid
name. Ala: 1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0; Cys:
0,1,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0; etc. This way to repre-
sent amino acids is to be preferred to a simpler system, like giv-
ing each amino acid an increasing number of 1,2,3 etc. This be-
cause the cardinal number may underlie a ‘distance’ between
amino acids. This is the same problem we face when using an
alphabetic letter code.
Table 8.1: List of Numerical Factors: In this table is found the numerical factors used to
convert the string of amino acid letters into numerical values. Atchley, Sandberg
and Kidera factors, all are present in the literature, and are all derived from
measurements of the amino acids physical/chemical properties. In contrast, the
arbitrary factor is a pure invention and has no biological background. In the first
column of the table is the factor name, in the second how many values compose
the numerical factor, and last is a list of what those value represent and how they
have been generated.
Once the single, duplets and triplets are gathered into the resulting k-means
clusters, the value for each cluster will be given by the sum of the values of the
original duplets/triplets now forming the new cluster. We can now pass to the last
step.
4 SVM classification
In order to measure the outcome of the classification, I compute for each experiment
the overall success rate (OSR). As described in [120], the OSR is defined by the








Where n is the number of classified instances, x the number of elements within
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the class and y the number of the class.
The greatest advantage of the OSR is that it is multiclass, symmetrical, ranges
from 0 (perfect misclassification) to 1 (perfect classification), and the result corre-
sponds to the observed proportion of correctly classified instances.
In this thesis, I choose to rappresent the OSR as a value between 0 and 100 and
refer to results as percentage of the overall success rate. See Table 8.2.
Example:
For a three class experiment, we test six elements:
Tests Blue Green Red
Blue 1 100





Table 8.2: Overall success rate —Example: Reported is an example calculation of the
overall success rate used in this thesis. We have a three-class system: Blue,
Green and Red classes and six test subjects, formed of 100 samples each. We
can see that Blue 2 has 20 samples misclassified as Green or Red. Green 2 is
completely misclassified. The OSR would therefore compute as: Class Blue
outcome 100 + 80, plus class Green outcome 100, plus class Red outcome
100+100, divided by the total numbernof classified instances, 600, results in:
480/600 = 0.8. In other words, 80% of samples are correctly classified.
8.1 Experiments and Results
The experiment with the SVM has been designed in the following way:
From each of the murine CDR3 repertoire, I randomly selected 10,000 se-
quences, then counted the number of times each 2-mers (duplets) and 3-mers
(triplets) is present in all the sequences, producing a vector of frequencies for the
400 duplets or 8,000 triplets (bag of words).
This process has been repeated 100 times for each repertoire.
I converted each duplet and triplet into the four numerical factor described is
Table 8.1, and used the k-means algorithm to reduce the 400 duplets and 8,000
triplets into 100 features.
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Therefore, if before we had 37 mice repertoires with different number of se-
quences, we now have for each repertoire two sets of 100 vectors of 100 features,
one set originated by the use of 2-mers, a.k.a. duplets, and another one by 3-mers,
a.k.a. triplets.
As seen in k-means algorithm Chapter 7, the k-means algorithm would exit the
algorithm after reaching the convergence phase. However, the number of iterations
needed for our dataset is too high, and the function kmeans of the R package
stats ends after 109 iterations.
The immediate consequence is that, because the initial cluster seeds are chosen
randomly, every time we run the program we will obtain different results. In other
words, the final clusters will be composed of different p-tuples every time.
In the original paper, this aspect had not been noticed. However, as I experi-
enced by running numerous SVM experiments repeating the k-means step, the final
SVM OSR does not actually change.
Despite the k-means results having no effect on the SVM classification results,
I consider this to largely undermine the use of a k-means algorithm to produce
clusters with a minimum biological significance.
After noticing this first issue I decided to run several more tests altering all
main parameters. I can summarise my tests into four experiments:
1. Run the experiment similarly to the one performed in [16].
2. Test the previous experiment applying different numerical factors.
3. Classifying by data point and antigens and, extending the experiment to the
new set of data.
4. Test different values for the number of k-means clusters.
8.1.0.1 Exp.1: SVM classification of repertoire group A
In [16], as described above, 100 numerical vectors of 100 features-long has been
originated by 100 random sub-samplings of a total of 10,000 sequences from each
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repertoire. With those the following experiment has been performed: a leave-
one-out cross validation using Support Vector Machine classification, in which one
repertoire is the test and the others are the training set.
In [16] only the repertoires from the first experiment has been used (Group A,
see Section 4.2), divided into four classes of elements: six control mice, six mice
sacrificed at day 5, day 7 and day 60.
The results that I obtained are in Table 8.3:
100 clusters per Duplets Triplets10k sequences
Atchley 83.33 62
Table 8.3: Results of experiment present in [16]: For this experiment 10,000 sequences
from each murine repertoire has been converted into 400 duplets and 8,000
triplets and gathered into two 100 features-long vectors. These two vectors have
been, previously, created by converting the sub-string of amino acid into numer-
ical values using Atchley factors and gathered into clusters using the k-means
algorithm. With this data has been performed: a leave-one-out cross validation
using Support Vector Machine classification method. Each repertoire is con-
sidered correctly classified when the major part of 100 vectors of triplets are
correctly classified, using the linear SVM classification function. We can see
that the result for duplets is much higher than for triplets, however, still higher
than the random classification (25%).
The result for this linear classification for duplets 83% and triplets 62% is
higher than the random classification 25%.
When I extend this analysis using the other numerical factors, I obtain similar
values, as reported in Table 8.4:




Table 8.4: Results for SVM classification using linear function and originating the data
point from different numerical factors: For this experiment I use the same
methodology used in Table 8.3, but using Sandeberg, Kidera and an arbitrary
numerical factor instead of the Atchley. From the table we can see that changing
the numerical factors does not produce a difference in terms of classification
result, and the results are similar with what obtained in table Table 8.3.
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We can immediately see that the results are not very different, as using nu-
merical factors with or without biological significance does not lead to significant
changes.
This new information suggests that the use of different numerical factors, be-
ing they derived from physical-chemical analysis or completely arbitrary, is not
contributing to the overall success rate for both duplets and triplets.
8.2 SVM classification of repertoire group A and B
In this new test, I performed the same experiment as before, but added the new
repertoires coming from the second experiment, Group B.
Because Group B repertoires have only three-time points (Control, Day 7 and
Day 60) and those do not match those in Group A, I chose to reduce the classes to
three: Controls (Control mice from A and B), Early (Day 5, Day 7 and Day 14) and
Late (Day 60 from A and B).
The results for the experiments with the new dataset are present in Table 8.5:





Table 8.5: Experiment with group A and B mice divided in three classes: Here I per-
formed an SVM classification using a linear function and as in Table 8.4 here
we see that the results do not seem to be influenced by the numerical factors.
As we can see, the results are higher than the random classification (33%) and
in general higher than the results for Table 8.4. This is because in the previous
experiment there were four classes and Day 5 and 14 were often misclassified one
for the other, while now these two time-points are in the same class.
For this experiment as for the one above different types of numerical factors
do not influence the outcome of the experiment.
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8.3 OVA vs. CFA mice
So far, we have tried to classify the repertoires on the basis of time after immu-
nisation. However, the mice used in the experiments have also been immunised
with two different antigens, CFA and OVA. Accordingly, I also tried to classify the
repertoires on the basis of the antigens.
To do so I performed two experiments: OVA vs. CFA with Group A, and OVA
vs. CFA with Group A and B. This was replicated for duplets and triplets.
When Group A was used, we have 18 repertoires, 9 OVAs and 9 CFAs, while
for Group A and B there are 28 mice, 15 OVA and 13 CFA.
The results are presented in Table 8.6:
100 clusters per Duplets Duplets Triplets Triplets
10k sequences Group A Group A & B Group A Group A & B
Atchley 61.11 53.57 55.55 57.14
Sandberg 72.22 55.55 55.55 57.14
Kidera 61.11 50 50 60.71
Arbitrary 66.66 61.11 61.11 39.28
Table 8.6: OVA vs. CFA mice classification per duplets and triplets: In this table are
reported the results of the classification for OVA vs. CFA mice repertoire from
Group A and Group A+B, repeated for duplets and triplets and for four different
numerical factors. We can see that classification results do not vary on the basis
of numerical factors and p-tuples used.
From Table 8.6 we can see that there is not variation in terms of duplets vs.
triplets or using different numerical factors, plus the results in terms of OSR are
not much higher that a random classification (50%). This implies that the SVM
classification method as previously used is not a valid method for the classification
of OVA vs. CFA mice.
8.4 Different number of clusters k-means
So far, all experiments have been performed using 100 clusters for the k-means.
However, choosing 100 clusters was an arbitrary choice.
Hence, in the following tables (Table 8.7 and Table 8.8) I have re-run the very
first experiment of Group A mice with four classes with an increasing number of
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clusters, until using the entire number of features, 400 and 8,000, and thus no clus-
tering at all.
Naturally, for the experiments without clustering, I avoided the use of numer-
ical factors and k-means algorithm, and used the values directly coming from the
BOW.
In Table 8.7, the results for duplets, classified with 15, 23, 100, 200 and 400,
can be seen.
Duplets 15 25 100 200 400
Atchley 62.5 83.33 83.33 70.83
79.16Sandberg 66.66 79.16 70.83 70.83
Kidera 66.66 79.16 70.83 70.83
Arbitrary 70.83 79.16 70.83 66.66
Table 8.7: Different number of clusters for k-means for duplets: For this experiment
I used an increasing number of k-means cluster result values, with the aim of
finding whether the difference in such numbers will improve the final OSR. As
we can see from the table, changing the number of clusters used do not lead to
advantages.
As we can see, the results do not show any consistent relationship between
number of cluster and OSR. Rather, if I use all possible 400 amino acid duplets, I
can completely avoid using numerical factors and the k-means algorithm without
losing OSR.
In Table 8.8, the results for triplets, classified with 25, 64, 100, 200, 500 and
8,000, are reported.
Triplets 25 64 100 200 500 8,000
Atchley 66.6 62.5 62.5 70.83 62.5
70.83Sandberg 70.83 58.33 66.66 62.5 58.33
Kidera 70.83 62.5 62.5 70.83 62.5
Arbitrary 70.83 58.33 62.5 75 75
Table 8.8: Different number of clusters for k-means for triplets: Here I repeated what I
tried in Table 8.7 but with triplets. As ever for triplets there is no difference in
the use of different numbers of clusters.
As with the results for duplets, the results for triplets do not show any consis-
tent difference between number of clusters and OSR.
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8.5 Test without numerical factors and k-means
This test is performed using all duplets and triplets, avoiding using the numerical
factors and the k-means algorithm entirely.
I can perform two types of tests per duplet and triplet: classification by sacri-
ficed date, a four class SVM classification of the Group A, a three class SVM with
Group A and B mice repertoires; and, classification by antigens, Group A, OVA
vs. CFA repertoires and Group A and B, OVA vs. CFA repertoires. The results for
duplets and triplets are presented in Table 8.9 and Table 8.10.
Duplets
Group A Group A & B Group A Group A & B
4 classes 3 classes OVA vs. CFA OVA vs. CFA
(data points) (data points) (Antigens) (Antigens)
79.16 81 66.66 60.71
Table 8.9: SVM tests using 400 duplets: In this experiment I repeated the test seen
in the previous section but using the total number of duplets skipping the k-
means/numerical factor steps. As we can see the results are as good as before.
Triplets
Group A Group A & B Group A Group A & B
4 classes 3 classes OVA vs. CFA OVA vs. CFA
(data points) (data points) (Antigens) (Antigens)
70.83 86.48 61.11 64.28
Table 8.10: SVM tests using 8,000 triplets: In this experiment, as for Table 8.9 I repeated
the test seen but using triplets. Also here the results are as good as before.
In Figure 8.1, there is a representation of whether the mice repertoires are
classified correctly or not. In blue are the correctly classified and in white are the
misclassified repertoires. The outcome of all four SVM tests previously discussed
and the outcome for duplets and triplets is reported.
In Figure 8.1, Group A four classes, we can see that Day 5 and Day 14 and
Day 60 all have some degree of misclassification, but if for Day 5/14 the repertoires
need some time to differentiate properly and change while fighting the infection,
the reason why D60 also has some misclassification does not appear clear. The
control mice are, instead, correctly classified. In our experience, the classification
of unimmunised controls vs. immunised repertoires is usually easy, and the results
correct.
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However, this is not the case for our second experiment, Group A and B, three
classes. Here, two control mice from the Group B are misclassified. This specific
group of control repertoires are often misclassified in almost all my classification
experiments, not only in this SVM test. This fact, along with the fact that also
Day 7 and Day 60 from Group B are a source of misclassification, in duplets and
triplets, led me to consider that there is some sort of batch effect between the two
groups of mice repertoires that is affecting my tests. However, we have seen above
that reducing the number of classes, merging D5/D7/D14 to one class, leads to less
misclassification and a higher classification performance.
The second set of experiments is OVA vs. CFA repertoires. Here, the OSR is
lower and the number of misclassified mice higher. Furthermore, the occurrence of
misclassification is spread in all classes of mice (Day 5, 7 etc.).
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Figure 8.1: Results of mice classification: In this plot I show which ones are the particular
mice repertoires that are correctly classified (in blue) and which ones are not
(white) for duplets and triplets and for all four kinds of experiments. On the top
is reported the classification by immunisation date, on the left-hand side only
the group A mice are divided in four classes (Control, D5, D14, M2) on the
right, group A and B are divided in three classes (Controls, Early and Late).
On the bottom are the OVA vs. CFA classifications, on the left-hand side only
the group A mice (mice groups: D5, D14, M2) on the right, group A and B
(mice groups: D5, D7, D14, M2 1, M2 2). It is also interesting to see that




8.6.1 K-means is not a valid clustering method
The k-means algorithm is a popular algorithm for unsupervised classification. How-
ever, given the high number of features and the limitations of the package’s func-
tion, to perform a classification of the amino acid combinations (duplets and triplets)
would be challenging and computationally expensive. We might still want to use it,
but this would not bring us any considerable advantages.
Finally, it is very important to know how many clusters to use before perform-
ing the k-means algorithm. Without this information, the only option is to test as
large a range as possible, and best find, depending on the situation, a method not
dissimilar to that employed in Table 8.8.
8.6.2 Numerical factors do not affect the SVM OSR
Using a numerical factor to convert the strings of letters into numbers is, no doubt,
a clever idea, and it is the obligatory path for whoever would want to research
the biological property of p-tuples. We have seen in the experiments in Table 8.4,
Table 8.5 and Table 8.8 that the use of one numerical factor with respect to another
does not lead to a great variation in the results. Furthermore, the use of numerical
factors with or without the biological background has no relevance whatsoever in
this analysis.
These considerations, and those done with the k-means, lead me to conclude
that the use of numerical factors and k-means are two steps of the method that can be
avoided. Indeed, neither would accomplish the task they were intended for. They do
not reduce the computational work and reducing the feature space does not improve
classification OSR.






After my work with the SVM classification, I started considering that the use of a
numerical vectors originated from all duplets and triplets might not be necessary.
Perhaps a better approach would be using a smaller subset of features: this could in
turn increase the overall success rate.
By doing SVM classification runs with a random number of random subsets
of triplets, I sometimes got an OSR much higher than ever before (See Figure 9.1),
therefore it was clear that a higher success rate was possible. The question was,
how to select a non-arbitrary subset of features that would increase my success rate,
and possibly be considered having biological relevance.
My idea was to try to classify one feature at a time, rate and sort them from the
highest to the lowest rate and use a progressively larger subset of features until I had
the best CDR3 success rate. I reasoned that if a single feature could be correctly
classified, perhaps a small collection of features with a high classification rate would
lead to greater success rate in the overall classification of the CDR3 repertoires.
My idea was to use one feature SVM; however, after some research, I found
the formula of the 1-Dimensional Bayesian Function (1-DBF). This function can
evaluate the likelihood of an element to be part of one of two classes, using mean
and standard deviation of the two samples.
The work presented here was published in [17].
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Figure 9.1: Random subset of 50 triplets: I tested if I could obtain high level of classifica-
tion using smaller set of triplets. In this plot I report 160 tests using 50 triplets,
rather than the normal 8,000. I randomly divided the 8,000 triplets into 160 sets
and performed the OVA vs. CFA SVM classification with Group A mice. The
results are interesting: we can clearly see a great fluctuation of results from a
minimum of 22% to a maximum of 94% of OSR. This proves, at least in theory,
that a smaller subset of features can produce higher classification results with
respect to the whole set. This result made me consider the idea to use such
smaller set and moreover stat researching a model to select a meaningful and
not random subset of triplets.
Before focusing on the 1-DBF, let us briefly examine Bayes’ theorem.
9.2 Bayes’Theorem
9.2.1 Overview
Bayes’ theorem is today considered one of the main theorems in statistics, and one
of the most applied formulae in science. Rather than being immediately celebrated
by the statisticians at the time of its publication, its importance grew steadily until
the middle of the last century. It is now considered essential in all statistics courses,
and applied in almost every field of research —not least in Bioinformatics, where it
has been applied extensively to the biological system analysis [121].
At first glance, Bayes’ theorem can seem confusing, counterintuitive, and hard
to grasp. We know that, for many, statistics is not intuitive, as with other aspects of
mathematics [122]. However, if we analyse the thought processes leading Bayes to
his theorem, we see that these are natural and logical ways of thinking.
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9.2.2 History of Bayes’ theorem
Bayes theory is named after the Reverend Thomas Bayes. Around 1740 Bayes
performed a thought experiment: he imagined putting his back against a flat, square
table, and launching a ball onto the table without knowing where it would land.
Then, he thought of launching a second ball, this time asking his assistant if the ball
landed to the left, to the right, in front of, or behind the first ball. Using this system,
he was able to narrow the position of the first ball with each new launch. It is not
possible to know exactly where the first ball landed using this system; but it created
a method, or a way of thinking, whereby each new piece of evidence improved the
estimate.
Bayes never published his idea. After his death in 1761, his friend Richard
Price found his notes, re-edited them, extended them (at some points), and eventu-
ally published them [123]. He contributed greatly to Bayes’ theorem —by modern
standards, we would normally refer to the theorem as the Bayes-Price theorem, giv-
ing the appropriate credit to Price. Despite Price’s work and the publication, the
theorem remained unknown until it was rediscovered, reinterpreted, and brought to
modern formulation in 1774 by Pierre-Simon Laplace in [124]. Here, it was stated
that “The probability of a cause (given an event) is proportional to the probability of
the event (given its cause)”. In more modern words: Bayes’ theorem describes the
likelihood of an event, based on prior knowledge of conditions that might be related
to the event.
9.2.3 Classical Representation and Examples




Where A and B are two events that we want to analyse.
P(A) and P(B) are the distinct and independent probabilities of the event A and
event B (prior probabilities).
P(A|B) (read: P of A such that B) is the conditional probability, the probability
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of the event A, given that the event B has occurred (posterior probability).
Vice versa, P(B|A) is the probability of B given A.
Therefore, this formula relates the prior probabilities to the posterior proba-
bilities, with the possibility to integrate new observations to an established model
based on previous observations.
Let us now move on from this formal terminology and look at some real exam-
ples.
9.2.3.1 Example 1:
In this example, let us consider a school composed of 60% boys and 40% girls, in
which all boys have a short haircut while the percentages of girls with long hair and
girls with short hair are equal.
We meet a student with a short haircut. What is the probability that the student
is a girl?
We can use the Bayes formula to answer this question. In order to do so, let us
identify the elements of the formula.
In this case, four elements are involved: the gender of the students, boys (B)
and girls (G); and the hairstyle, long (L) or short (S). The hairstyle events are con-
nected and dependent on the gender of the student and those are therefore our de-
pendent variables. The gender of the students is the independent variable.
From the composition of the school, we can compute that the independent
probability the student is a girl (event G) is 40% P(G). Conversely the independent
probability the student is a boy (event B) is 60% P(B).
The probability that a student has a short haircut (event S) considering the
entire school P(S) is: all males plus half of females 60%+(40%/2) = 80% of all
students.
The probability that a student has a long haircut (event L) is: P(L) : 1−P(S) =
20%.
The dependent probability of a student with short hair, given that the student is
a girl P(S | G), is 50%. This is because the girls are equally divided between long
and short haircuts.
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The dependent probability of a student with short hair, given that the student is
a boy P(S | B), is 100%, given that all boys have short hair.
Having established this, we can now apply the formula to compute the condi-
tional probability:
P(G|S) = P(G)P(S|G)p(S) = 0.5×0.40.8 = 0.25→ 25%
P(B|S) = P(B)P(B|G)p(S) = 0.6×10.8 = 0.70→ 75%
(9.2)
In conclusion, the probability that the student with short hair is a girl is 25%.
Interestingly, we could have computed P(G | S) even without knowing P(S) by
doing:




0.8 = 0.25→ 25%
(9.3)
9.2.3.2 Example 2:
Let us assume that a test for a disease is positive. We know that the test performed
has an accuracy of 99%, and that the disease it tests for affects one person out of a
thousand. What is the likelihood of having the disease?
One might say 99% because of the accuracy of the test. This is not correct,
because the accuracy of the test actually means the percentage of testing positive
(event T), given that you have the disease (event D) is P(T | D). What we really
want to know is the probability of having the disease, given that the result of the test
is positive: P(D | T ).
If the P(D) is equal at the percentage of the population 0.001%, we can now
apply Bayes’ theorem, so that we have:
P(D | T ) = P(T |D)P(D)P(T ) =
P(T |D)P(D)
P(T |D)P(D)+P(T |−D)P(−D) =
0.99×0.001
0.99×0.001+0.01×0.999 = 0.09→ 9%
(9.4)
9% is less scary than 99%. But why is this value so low?
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We know that the disease affects only one person in one thousand and that the
test has a 99% accuracy, therefore in a sample of one thousand, only one person
would be a true positive, but ten people would results as false positive. See Figure
9.2:
Figure 9.2: Positive and false positive results of the test: In this picture, we see a sample
of 1,000 people tested with a test which has 99% accuracy. A priori, we know
that only one individual in 1,000 is positive for the test (in red), and all the
other results are negative. However, because the test is only 99% accurate, we
are going to have 10 individuals who will test positive, even though they do not
actually have the disease, thus false positive (in grey). Therefore, according to
the Bayesian theory, the probability of a true positive result for a 99% accuracy
test for an incidence of 1 over 1,000 is not 99%, as one could think, but only 1
over 11 (all the person considered positive, true and false combined) thus, 9%.
Therefore, an individual resulting positive has a 9% possibility to be a true
positive.
1/11 = 0.09→ 9% (9.5)
Now, if we repeat the test and the result is still positive, how much is P(D|T )?
Again, we can use Bayes, using the previous result as our new independent variable
P(D), therefore:
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P(D | T ) = P(T |D)P(D)P(T ) =
P(T |D)P(D)
P(T |D)P(D)+P(T |−D)P(−D) =
0.99×0.9
0.99×0.9+0.01×0.91 = 0.9073→ 90.73%
(9.6)
A third time would be 99.89% and so on.
Chapter 10
Bayes’ theorem as classification
method
10.1 Overview
The 1-Dimensional Bayesian Function (1-DBF) formula has been reported and de-
scribed in [97]. Here, I will discuss the formulation of the formula and analyse its
output in two examples.
Given two classes C1, C2, different and dividable by a hyperplane (see SVM
for definition). The posterior probability that a new observed element x belongs to
a class k, is given by:
P(Ck | x) = P(Ck)p(x |Ck)p(x) (10.1)
Where P(Ck) is the a priori probability of class k. p(x |Ck) is the probabil-








p(x)dx = 1 (10.2)
We assume that the one-dimensional data x, which belongs to class k, obey the
normal distribution rules, with the mean µk and σ2k (the variance) given by:
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According to Bayes’ theory, the optimal classification of x is given to the class
with the maximum posteriori probability p(x |C1)> p(x |C2) or vice versa.
Instead of comparing the posteriori probabilities, [97] compares the logarithms
of the posteriori probabilities. Simplifying for one class, the result is:








Thus, the Bayesian decision function for the two classes is given by:















If DBayes(x)> 0, x is classified into class C1, and if DBayes(x)< 0, class C2.
10.2 Example 1:
Let us now see how the formula can be applied to an everyday life example.
In this example, we want to identify the sex of an unknown person using only
their height.
To do so, first we have to collect the data from the population. The results
indicate that the heights of a group of women (h f ) are normally distributed between
145 cm and 185 cm, and the heights of a group of men (hm) are normally distributed
between 165 cm and 205 cm, with an overlap of 20 cm between hf and hm (165-185
cm). See Figure 10.1.
After this, I created a test set formed of 10 individuals, and predicted the sex of
each individual in the test set using Equation 10.5. The results can be seen in Table
10.1.
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Figure 10.1: Example of two classes within a population: In this plot I report the distri-
bution of height of a hypothetical population divided by sex. On the left-hand
side, in red, there is the distribution of height for the female class and on the
right-hand side the male distribution. We can see that on average the men
are taller than women and that there is an overlapping are between the two
classes. Given this data we could use the height of individual of unknown
sex as predictor of his/her sex. And the more the height is far from the mean
between the two classes and the surer we could be.











Table 10.1: Sex prediction using an arbitrary height distribution: Continuing with the
example see above, let us see how using male and female human population
distributed in base of their height would work as predictor of unknown individ-
uals’ sex. In the left column we have the heights of 10 individual of unknown
sex, in the central column the result of the 1-DBF formula and in the right col-
umn the predicted sex for each individual, those are predicted as male if his
result is lower than zero and female vice versa.
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When the result is positive, the individual is assigned as female (F). Otherwise,
the individual is assigned as male (M).
From the table, we see that the further a result is from zero, the more certain
we can be about the prediction.
10.3 Example 2:
Let us now analyse the results of Equation 10.5 by modifying the two elements
considered in the formula, mean µ and standard deviation σ .
By setting different values for µ and σ , let us see the properties and the be-
haviour of 1-DBF.
We see four different scenarios described below:
µ1 = µ2, σ1 = σ2
µ1 = µ2, σ1 6= σ2
µ1 6= µ2, σ1 = σ2
µ1 6= µ2, σ1 6= σ2
(10.6)
If we plot these four scenarios (as in Figure 10.2), we can suggest that the
smaller the overlap between the areas, the more confident we can be in the result of
1-DBF.
From these four scenarios (Figure 10.2), we can see that if the more two pop-
ulations have a different mean the less is the area shared between them, Therefore,
we would have a higher success rate by applying the 1-DBF.
Let us now perform these four hypothetical scenarios and see the results.
Table 10.2 represents 48 different experiments, representing the four different
scenarios with different parameters. These experiments were made with the leave-
one-out method with 10,000 elements.
Scenario 1, top left: If mean and standard deviation are equal, the populations
are equal as well. There is a complete overlap between the populations, and we
cannot be sure of the classification. This method has the same reliability as flipping
a coin.
Scenario 2, bottom left: The two populations lie on the same mean. The only
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Figure 10.2: Four scenarios for two populations: Within this plot are represented four
cases of two population with equal or different standard deviation and mean.
The four cases are: sub-fig. a) Same mean and standard deviations. In this
case the two populations are equal, and the overlapping area between the two
is equal to the area under the curves; sub-fig. b) Different mean and equals
standard deviation. In this scenario the two populations have no overlapping
area, and no individual could belong to both of them; sub-fig. c) Equal mean
and different standard deviations. The two populations have an overlapping
area equal to half of each single population area; sub-fig. d) Different mean
and standard deviation. Similarly, to sub-fig. b, a difference in mean produces
a decrease in the area shared between the two populations.
improvement is when we increase the difference of the standard deviation. This
is due to a decrease in the overlap between the two populations. In any case, the
success of this process increases slowly, and it could never lead to a perfect classi-
fication.
Scenario 3, top right: The results increase, moving from left to right and from
bottom to top. Gradually, there are narrower standard deviation and a higher dis-
tance of means, until there is no overlap at all. We can see immediately that small
changes in the means lead to greater results. The mean has a greater impact on the
formula, but its contribution is still not enough for all scenarios.
Scenario 4, bottom right: This last scenario confirms the previous one. Moving
from left to right (thus increasing the distance of means) the results increase. From
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Mean of population 1 and population 2
1, 1 5, 5 10, 10 1, 2.5 1, 5 1,10
SD
1, 1 50 48.32 49.66 77.41 97.64 100
5, 5 49.75 49.47 49.79 55.39 65.22 81.33
50, 50 48.95 49.49 49.76 50.74 50.75 53.73
102, 102 49.38 50.48 49.95 50.11 50.62 51.76
1, 5 81.97 82.35 82.16 82.8 86.36 95.55
1, 25 95.46 95.45 95.41 95.37 95.47 95.57
1, 50 97.49 97.53 97.61 97.48 97.67 97.43
1, 100 98.62 98.71 98.71 98.71 98.69 98.57
Table 10.2: 1-DBF Test experiments: This table reports the classification results of 48
experiments of two populations with different means of standard deviation,
trying to reproduce what we saw in Figure 10.2. For each experiment, the
populations are composed of 100 points, of which distribution has a set mean
and standard deviation. The results can be divided into four groups. Top left
(in yellow), populations with same standard deviation (SD) and mean: here the
classification results are all around 50%, thus equal to random classification.
If we recall Figure 10.2, on the top left scenario the two populations were
identical; therefore, the formula assigns the point with the same accuracy of
randomness. The average of all these experiments is 50%. Top right (in red),
same SD and different means: for this group of experiments we can see that
the success rate grows the smaller the SD and the larger the distance between
the means. In Figure 10.2, we saw that this scenario was the one with smallest
shard area. The average of all these experiments is 77.41%; but the highest
accuracy value is also present here (100%). Bottom left (in green), different
SD and equal mean: for this group the success rate grows, with a particular
increase in one of the SD. However, even with small variations of SD and mean
the success rate is already high. Average of all these experiments is 81.97%.
Bottom right (in blue), different SD and mean: in this scenario we can see that
the success rate grows when one of the SD grows and, in this group, we have the
highest average success rate of 82.8%. From this table we can understand that
the further the mean is between the populations and the smaller the standard
deviation, the higher the success rate.
top to bottom, the increase of one standard deviation decreases the overlap, leading
to better results.
In conclusion, the best results occur with the use of great differences in means
and small standard deviations.
Chapter 11
Feature selection using one
dimensional naı¨ve Bayes’ classifier
increases the OSR of support vector
machine classification of CDR3
repertoires
In this chapter I am reporting my work made with the 1 Dimensional Bayesian
Function (1-DBF) for the classification of the murine CDR3 repertoires. The work
reported herein has been published in Bioinformatics [17].
11.1 Overview
As we saw in the previous chapter, I can reach an overall success rate of circa 60-
70% for the classification of OVA and CFA mice repertoires by applying the SVM
classification. In this experiment, I wanted to improve such success rate: to do so,
I thought to introduce a ‘selection step’ between the BOW and the SVM in which




From each mouse repertoire, 10,000 sequences have been selected, divided into k-
mers and counted, forming one numerical vector. This process has been repeated to
include single amino acids (singles), duplets, triplets, and quadruplets.
In the previous experiment, we continued by classifying the repertoires using
the SVM classification system. However, here my intention was to apply a filtering
system that would rank the feature, before being downsized and used in the SVM.
Therefore, adjustments needed to be made to the process.
The system chosen to evaluate each feature is the 1-DBF explained in the pre-
vious section. Similarly to the SVM, this method requires a training and test set
in order to work properly. If we would, train/test the 1-DBF and use its results to
train/test the SVM we will fall into an overfitting error.
Therefore, the right approach is to leave one mouse repertoire as a test set for
the SVM, then train/test the 1-DBF, then train the SVM and finally test it with the
test set left out at the beginning. In this way, this became a double leave-one-out
experiment.
In further detail:
• A first mouse repertoire is left aside to be used as the SVM test sample. This
mouse is called the “outer test set”.
• The remaining repertoires are the “outer training set”. This is used for the
1-DBF process. Here again, one repertoire is left out as an “inner test set”,
while all the others form the “inner training set”.
• Within the 1-DBF each “inner test set” is composed of a single feature of the
codeword (a.k.a. one p-tuples) and the same feature in all other repertoires
form the “inner training set”. In this way we get a classification value for each
single p-tuple.
Left to do, then, is to sort the p-tuples in decreasing order. One result is pre-
sented in Figure 11.1, showing all duplets features ranked by their classification
value by the 1-DBF.
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Figure 11.1: Example of duplets sorted by 1-DBF: In this plot is reported the OSR value
for each duplet for each mouse repertoire sorted in decreasing order. Each line
in the plot is a different repertoire. We can see that a handful of duplets have
a very high OSR value which drops quickly to the 50% area, and one handed
circa of duplets have values lower than 25%. The duplets with zero values are
the duplets absent in the repertoire hence the value cannot be computed.
As we can see from Figure 11.1, the features with a very high classification
rate comprises of a small group, then it decreases rapidly to low values. Null val-
ues occur due to the fact that many features are partially or totally absent in each
repertoire.
Once all features are ranked and sorted, we can test the original “outer test set”
of the SVM.
Here, contrary to the 1-DBF stage, the train/test is not formed by one single
feature, but by a subset of all features. We start with a subset of two highest p-tuples
and add one feature at time until all are considered. Figure 11.2 shows the results of
the SVM classification for single amino acids codeword and the first 100 duplets,
triplets and quadruplets.
From Figure 11.2, we can see that success rate usually starts from a low value,
reaches a maximum pick quickly, and then decreases when the number of features
increases.
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Figure 11.2: Success rate for singles to quadruplets for the first 100 p-tuples: In this
plot, I report the success rate for single amino acids and the first 100 duplets,
triplets and quadruplets. After I had ordered the p-tuples using the 1-DBF, I
computed the SVM classification score using an increasing number of tuples
(starting from the first two, then proceeding with the first 100 —or, in the case
of singles, to 20). We can see that: for single, the highest score is reached
when all features are used with a score higher than 80%; for duplets, the
score floats between the 70-80% value; for triplets, after a spike around 12-
14 features with the highest OSR score, the classification value drops around
60%; and for quadruplets, the classification scores range over 70-80% with
smaller variation after the thirtieth position.
The minimum number of features needed to obtain the highest SVM classi-
fication value seen in Figure 11.2 is computed post-facto, as it is not possible to
determine it a priori.
The highest result for each p-tuples is reported in Table 11.1:
From Table 11.1 we can see the result for each of the p-tuples. The highest
value is for the triplets, where only one mouse is misclassified (and which is, inci-
dentally, always misclassified).
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Singles Duplets Triplets Quadruplets
Day5 1 100 100 100 100 OVA 1
Day5 2 100 100 100 100 OVA 2
Day5 3 90.9 100 100 100 OVA 3
Day14 1 100 100 100 100 OVA 4
Day14 2 100 100 100 100 OVA 5
Day14 3 100 100 63.6 60 OVA 6
Day60 1 1 100 100 100 0 OVA 7
Day60 1 2 81.81 100 100 100 OVA 8
Day60 1 3 100 100 100 100 OVA 9
Day5 4 100 100 100 60 CFA 1
Day5 5 100 18.1 100 100 CFA 2
Day5 6 100 100 100 60 CFA 3
Day14 4 0 0 0 20 CFA 4
Day14 5 100 100 100 100 CFA 5
Day14 6 90.9 100 100 60 CFA 6
Day60 1 4 0 0 72.7 0 CFA 7
Day60 1 5 100 100 100 100 CFA 8
Day60 1 6 0 90.9 100 100 CFA 9
OSE 83% 89% 94% 83%
# of features 17 17 12 11
Table 11.1: Maximal SVM success rate with minimal number of p-tuples: In this table,
I report the maximal SVM success rate generated by the minimal number of
p-tuples ordered by the 1-DBF. In each row is present the mouse repertoire
label as timepoint (first column) and antigen-infected (last column), and the
classification score for each different p-tuples (central columns). In the last
two rows is present the success rate and the number of features used for this
classification. All misclassified mice are highlighted in red. All classification
score range between 83% and 94% with the highest score produced by the first
12 triplets.
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To prove that this improvement in the success rate is not driven only by a
smaller number of features, but is due also to a higher informative feature, I repeated
the SVM experiment 100 times. I used an increasing size of random triplets: 25,
50, 75, 100, 125 and 150. The result is reported in Figure 11.3.
Figure 11.3: Success rate by 1-DBF vs. random subsets: In this plot I tested if the clas-
sification score of 94% with 12 triplets could be reproduced using random
subset of triplets of increasing size. In the plot, the thin red line is the be-
haviour of the success rate (as seen in Figure 11.2), the boxplot is the results
of 100 SVM test with 25, 50, 75, 100, 125, 150 random triplets. The solid
red line is the mean of each boxplot. We can see that all results are lower
than the one performed with our ranked triplets. This plot proves that the re-
sults obtained with the combination of 1-DBF-SVM cannot be reproduced or
originated stochastically.
All the results for the 100 SVM experiment with random triplets are reported
in Figure 11.3. We can now see how the average results (solid red line) is much
lower than our results (thin red line).
Our highest value is 94%, which was never reached by the random tests; ranked
triplets kept outperforming the random test, even after 150 features.
Considering the very high results with the 12 triplets, I wanted to see where
these triplets are present on the CDR3. The result is presented in Figure 11.4.
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Figure 11.4: Position of the 12 selected triplets on the CDR3: In this plot is reported
the position of each of the selected 12 triplets on the CDR3. For each plot I
counted the starting position of each triplets for all CDR3 of length 16 in the
entire repertoire. On the y-axis is reported the number of times present and, on
the x-axis, the starting position. As we can see that some triplets are presents
in unique positions like: ASS, QYF, TQY, SPQ, DQD and TDQ. Other are
more spread and mostly present in the left-hand side of the CDR3.
As we can see, the great majority of all triplets are found principally at the
beginning of the central region of the CDR3, in particular around the 5th amino
acid position.
11.3 Discussion
Thanks to the use of 1-DBF as features selection method, I was able to boost the
success rate. With the use of triplets, the overall classification OSR went from 61%
of Table 8.10 to 94% of Table 11.1. This is a very significant result, considering
that this type of classification has been one of the hardest. Only with this method I
could obtain such good values.
This result demonstrates that specific antigen immunisation can give rise to
changes in the TCR repertoires which are consistent and trackable, even when co-
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exposed to a mixture of other antigens. Even so, genetically identical mice may
contain largely disparate set of repertoires —we see this in our control mice.
This result with low level features of protein sequences like triplets support the
idea [16] that triplets are the best elements for the study of CDR3. Triplets seem
to be a good midpoint between having a small patch of sequences, but still being
informative for computational and biological analysis.
Therefore, these are promising indications for applying this kind of approach
to the analysis of clinical samples for the prognosis and diagnosis of patients in the
contexts of both infectious and non-infectious (e.g. cancer, autoimmunity, trans-
plantation) disease [17].
The method used here is composed of a double leave-one-out cross-validation
system in which I use the 1-DBF to filter and evaluate the features, and then apply
the SVM methods to search a subset of those features that produce an optimal result.
In recent years, other studies have been performed in different fields of
machine learning with an approach similar to the one adopted here: high-
throughput data feature selection followed by a classification method, often SVM
[125][126][127][128][129][130][131][132].
All of these methods can be divided into a filter method (which is defined as
a criterion to rate and sort the features) and a wrapper/embedded method (in which
a classifier is used to search an excellent subset of all features) [133]. However,
to avoid any over-fitting issue, the best solution is to apply a double leave-one-out
cross-validation; but, at least for my method, it requires a long time and great com-
putational effort. This is probably the most impactful limitation of this approach.
In addition, if applied to larger databases, it would probably produce even more
accurate results, but at the cost of increased calculation, effort and time.
Using the 1-DBF to find a way to select the most informative p-tuples, I se-
lected 12 triplets that are in positions that are considered of primary importance for
the interaction with the peptide. They mostly lay around position 5, this area of the
CDR3, as see in section 3.8 and in [12] has been considered relevant for peptide
recognition by CDR3.
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This result suggests that the use of the 1-DBF has not only increased the clas-
sification rate of the repertoires, but it has also selected potentially relevant position
and triplets for the antigen recognition.This method is not a valid clinical diagnosis
tool [134], but at least a promising classifier of CDR3 sequences in accordance to
their specificities [135][136].
The Hidden Markov Model as a way




Introduction on Markov Chains
Models
After my work on the SVM and the Bayes’ theorem, reported in the previous sec-
tions, in the last year of my doctorate, I moved my attention to another important
machine learning and data mining technique: the Markov models.
The Markov Chains (MC) [137][138] and the Hidden Markov Model (HMM)
[139] are powerful statistical models that can be applied in a variety of different
fields, such as: protein homologies detection [140]; speech recognition [141]; lan-
guage processing [142]; telecommunications [143]; and tracking animal behaviour
[144][145].
HMM has been widely used in bioinformatics since its inception. It is most
commonly applied to the analysis of sequences, specifically to DNA sequences
[146], for their classification, [147] or the detection of specific regions of the se-
quence, most notably the work made on CpG islands [148].
In the following chapters, I illustrate my findings in the application of a spe-
cific program, Hammock [149], a hidden Markov model-based clustering algorithm.
This program can find conserved motifs in short amino acid sequences and its re-
sults can reveal interesting characteristics of the CDR3 sequences and motifs of the
repertoires.
Furthermore, I create a SVM classification system in which the features of the
SVM are not the sub-string of the CDR3 sequences, but the results of Hammock
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turned into Profile HMMs.
In the following chapters, I will present an introduction to the Markov chain
and HMM, and their application with protein sequences. This will be followed by
an explanation of the programs used, and finally by the analytical experiments I
performed.
Chapter 13
Hidden Markov Model Theory
In the first part of this chapter, I will describe the classical types of Markov
Chain and HMM that are usually studied. In the second part, I will focus on a
special case of HMM applied to protein sequence analysis, named Profile HMM
[150][151][152].
Profile HMM represents a subgroup of HMM called “Left-to-right HMM”
[153]. They may appear disorienting to the reader familiar with classical HMM.
Nevertheless, Profile HMMs are the state of the art for sequence analysis, and I
hope to provide a clear explanation.
13.1 Overview
The Markov Chain models can be applied to all situations in which the history of a
previous event is known, whether directly observable or not (hidden). In this way,
the probability of transition from one event to another can be measured, and the
probability of future events computed.
The Markov Chain models are discrete dynamical systems of finite states in
which transitions from one state to another are based on a probabilistic model, rather
than a deterministic one. It follows that the information for a generic state X of a
chain at the time t is expressed by the probabilities of transition from the time: t−1.
In HMM, the previous rules are observed, but the observer can only see the
output of the function associated with each state —not the states directly. In other
words, the observer can see the event produced at the time t but cannot observe the
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state that has produced the output.
13.2 General Theory
13.2.1 Markov Chain
A Markov Chain provides a theoretical model to describe the behaviour of a
discrete-time system.
Definition: For a finite state space S = {s1,s2, ... ,sN} with a sequence of ran-
dom variables X1,X2, ...Xn, assuming values in S for which the transitional proba-
bility P, of the state s j at the time t, is given by the transitional from the state si and
the time t−1, with probability pi j, thus the probability of transition from state si to
s j (Markov assumption).
In other words, the probability of a state S, at time, is given only by the imme-
diately preceding state; therefore, all events before t− 1 can be ignored. For this
property, the Markov Chain is called memoryless.
The Markov assumption is also known as the Markov Chain of first-order. A
Markov Chain of second-order would have the observation at time t depending on
time t−1 and time t−2; however, Markov Chains of orders higher than 1 are rarely
used.
As a consequence of the Markov assumption, the entire behaviour of a Markov
Chain can be described using a transition matrix. The dimension of a transition
matrix is the number of states of the Markov Chain, and all the elements describe
the probability of moving from one state to another (or back to the same state):
qi j = P
(
qt = S j|qt−1 = Si
)
1≤ i, j ≤ N




a1,1 a1,2 · · · a1,n
a2,1 a2,2 · · · ...
...
... . . .
...
an,1 an,2 · · · an,n

(13.1)
Where the following property is true:
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ai j = 1 (13.2)
The Markov Chain can be described as a triple (S,X ,P), a set of states S, with
X random variables and a transition probability matrix P.
13.2.2 Example






Every time the system is in the state A, there 90% probability that system will
remain in state A for the next time. Every time the system moves from state A to B,
it will stay in B for 80% of the times.
We can compute the probability of having the succession of events ABBAB,
given a starting A, to be:
p =
P = P(AA)P(AB)P(BB)P(BA)P(AB)
0.9 ·0.2 ·0.8 ·0.1 ·0.2 = 0.00288 = 0.288
(13.4)
13.2.3 Hidden Markov Models
As seen so far, for the Markov Chain, each state corresponds to an observable event.
However, this type of model appears to be too restrictive, and it cannot be applied
to many situations of interest.
The situation might occur in which a stochastic process producing a set of
outputs has an underlying process that is not observable, thus the ‘hidden’ label.
The Hidden Markov Models can be considered as a quintuple N,M,A,B,µ
with the following elements:
1. N, hidden states.
2. The observable symbol per state M. What type of output can come out from
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each state.
3. The transition probability matrix A = ai j.
4. The probability distribution of the observable output.
5. Probability for the initial state, µ .
Transition matrices and emission probability are usually calculated with a
pseudo-count [154][155]. This consists of adding a small quantity, typically 1, to all
the states in all positions, before calculating the probabilities, to avoid zero-values
that could compromise future results.
13.3 Application on Biological sequences
As seen thus far, MC and HMM are powerful methods that can be used for a large
variety of purposes. However, we use a special case of HMM named Profile HMM
for the study of biological sequences. In the following section, my description of
this system should explain the reasoning behind the use of Profile HMM.
13.3.1 Analysis of a MSA
Let us consider a set of functionally related DNA sequences. Our objective is to
characterise them as a ‘family’, and consequently identify other sequences that
might belong to the same family [154].
We start by creating a multiple sequence alignment to highlight conserved po-
sitions:
A C A − − − A T G
T C A A C T A T C
A C A C − − A G C
A G A − − − A T C
A C C G − − A T C
It is possible to express this set of sequences as a regular expression. The
family pattern for this set of sequences is:
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[AT ][CG][AC][ACGT ]∗A[T G][GC]
Each position in the regular expression represents the nucleotides in the chain.
Multiple options for each position are gathered in a bracket: thus, the first element
could equally be an A or a T, the second one a C or G, and so on. The element
indicated with a * represents a gap area: only the A is not bracketed, because it is
the only possible option of that position.
The regular expression is useful because it allows us to spot the pattern of this
family of sequences in a visual and simple compact view. However, the regular
expression is not an adequate method when establishing whether other sequences
are part of this family.
As an example, let us consider two new sequences 1 and 2:
1 : T G C A − − A G G
2 : A C A C − − A T C
Both sequences fit the regular expression given above and, based on that alone,
they could be considered part of the family. However, we can see that the first
sequence is formed by the nucleotides occurring the fewest times in the multiple
sequence alignment, while the second is formed by those most common. Indeed,
in the first position, the T is present only once in the multiple sequence alignment,
while A in all other sequence, similarly for the in second position, the G only once
and C, for all remaining sequences.
We need a way to measure the “distance” between a new sequence and the
original set of family sequences. To solve this problem, we can use MC and HMM.
13.3.2 Markov Chain
The nature of the state is arbitrary: in this case, we can choose to take four elements
present in the sequences, thus: A, T, C, G, and create the following Markov Chain
(see Figure 13.1).
From the model in Figure 13.1 we can start computing the probability of tran-
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Figure 13.1: Graphical representation of a Markov chain model for DNA: Each circle
represents a state of the chain: four states connected with the DNA nucleotides
(A, C, G, T). Each edge is the probability of transition from one state to an-
other or to itself.
sition in accordance with the alignment seen previously. As such, we can begin
calculating the probability of passing from the nucleotide A to G or from G to T, for
example, and forming a transition matrix.
Using the transition matrix, it is possible to obtain the probability of a new
sequence through the following relation:





Where the probability of a sequence (with respect to a transition matrix (Mt))
is given by the product of the transition probability from one state to another of the
sequence.
The result obtained through this equation is an indication of how much a se-
quence can be considered part of a family: the higher the value obtained, the greater
the extent to which a sequence can be considered part of the family.
However, the transition matrix is being obtained regardless of the positions of
the states within the sequences. This aspect is not negligible, particularly regard-
ing the study of DNA and protein sequences, where undeniably the position of a
nucleotide is more important than its numeric presence.
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In order to adapt the Markov Model to the study of sequences, the concept of
Profile HMM has been introduced.
13.3.3 Profile HMM
The Profile HMM is a variation of the Markov Chain in which the position of a
multiple sequence alignment become the states of the model; the transition matrix
is the probability to pass from one state/position to the next [154]. In this way, the
probability of emission for each state is introduced, and thus the probability to have
a particular nucleotide on that state of the Markov Chain.
[AT ][CG][AC][ACGT ]∗A[T G][GC]
We can rewrite the regular expression presented in the previous section (and
above), delivering the assumption of the previous paragraph. Figure 13.2 clarifies
this concept:
Figure 13.2: Scheme of a Profile HMM: In this plot the multiple sequence alignment taken
as example above, has been represented as a Profile HMM, each position of
the multiple sequence alignment is a state, for each amino acid are reported
the probability of emission of a nucleotide in that state and, the arrows are the
transition probability between the state. Source [154].
Figure 13.2 is a visual representation of the application of the HMM method
to the case presented here. Each of the boxes is a state of the HMM, corresponding
to the position of the multiple sequence alignment or to each group of the regular
expression. Inside the boxes are the possible emissions of the state and the proba-
bility of each one, while the external arrows exemplify the probability of transition
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from one state to the other.
The state on the top of Figure 13.2 is the only one with the property to stay
still, rather than to move to a different state. This property can be used to model an
insertion state.
To generalise the scheme even further, more states can be added with different
properties until a Profile HMM is formed. The general standard architecture of a
Profile HMM is presented in Figure 13.3:
Figure 13.3: General representation of the structure of a Profile HMM: This is a gen-
eral representation of the structure of a Profile HMM. There is both a ‘begin’
state and an ‘end’ state. The square represents the matches’ states (M), and the
circles and diamonds represent deletion (D) and insertion states (I). The addi-
tion of insertion and deletion states make it possible to train and test sequences
of different length. The arrows are the transition probability and because for
each position, except for the Begin and End state. Because there are nine ar-
rows, this type of Profile HMM is called Plan 9. Original picture from [154].
In Figure 13.3, the Profile-HMM has three hidden states [150], plus a “Be-
gin” and “End” state. The squares are the “matches” states, which represent the
frequency (emission) of the amino acid or nucleotides.
The diamonds are called the “insert state”. They are used to model the gap
insertions of the alignment. They are usually used to test sequences longer than the
consensus sequences [150].
The circles are the “deletion states”. They play the role of the silent or null
state. They do not match residues or gaps and are used to jump from one column to
another. These are usually used for sequences shorter than the consensus sequences.
“Begin” and “End” states have been introduced to help the transaction at the
beginning and the end of the Profile HMM. They do not produce any emissions.
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The arrows represent the transition probabilities. In Figure 13.3, nine arrows
are presented in a module (M, I, D states). This configuration is named Plan 9.
Profile HMM are widely used in biological sequences analysis. They have been
proven to be useful for protein classification, motif detection, multiple sequences
alignment [156], and protein secondary structure prediction [157]. In general, all
of them can be summarised in terms of their major uses: aligning a sequence to a
profile and scoring a sequence against a profile.
To evaluate a sequence against a profile and obtain a score, more efficient dy-
namic programming methods than the ones presented above are available. The For-
ward algorithm [158] identifies the likelihood of a sequence; the Viterbi algorithm
[159] identifies the most probable “path” to generate a given sequence; and the
Forward-Backward (Baum-Welch) algorithm, used also to train the Profile HMM.
Chapter 14
HMM-Based Programs
Below are brief descriptions of the three main programs I used in the work presented
here.
14.1 HMMer
HMMer [160][161] is a free program, generally used to identify homologous DNA
or protein sequences by comparing Profiles HMM to a single sequence or entire
databases.
An alternative programme mentioned in the literature is SAM [162]. SAM is a
low-level program with few automatic options, and it has not been updated since its
first publication. It has also been referenced in fewer publications and has a smaller
online community.
In contrast, a newly upgraded version of HMMer (HMMer3) was released in
early 2015 [163]. It has been used for many recent papers. References and expla-
nations of the underlying algorithm can be found on its own website [161], as well
as in academic texts [153][164].
HMMer is generally used to identify if a sequence or a group of amino
acids/nucleotides sequences can be considered as member of a family present in
private or public databases, as in the case for Pfam [147][165].
From a set of aligned sequences, HMMer allows the creation of a Profile
HMM and the subsequent comparison of the HMM to a single sequence or an en-
tire database. Sequences that score higher than a chosen threshold are considered
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homologous to the sequences forming the profile-HMM.
In HMMer, there is a small variation in the architecture of the Profile HMM.
In particular, there is no transition allowed from delete states to insert states, or vice
versa.
Figure 14.1: Plan 7 in HMMer: Graphical representation of Profile HMM used in Ham-
mock. This kind of Profile HMM architecture has been named Plan 7 because
the number of non-zero transition (arrows) in a module (M, I, D, i.e. match,
insertion and deletion states, respectively) are reduced to seven. This is in
contrast to a normal Profile HMM, which would be Plan 9. This is present in
Figure 13.3. [154].
This architecture has been named Plan 7 (see Figure 14.1) because the number
of non-zero transition (arrows) in a module (M, I, D states) are reduced to seven
[166]: in fact, there are no transition from delete to insert states or conversely from
insert to delete [153]. HMMer relays on the Viterbi algorithm for the plan-7 archi-
tecture, the algorithm will compute the most probable/maximum-likelihoodre path
through the state model [167].
14.2 HH-Suite
HH-suite [168] is an open-source program able to perform pairwise alignment of
hidden Markov models. Thanks to this, it is possible to identify if a protein sequence
belongs to a database of HMM protein families. This program has been used in a
plethora of different bioinformatics tools such as ClustalΩ [169] and Hammock,
among others.
In this work, we use principally the functions hhalign and hhmake. Using
the latter, we can turn the resulting multiple sequence alignment of sequences found
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by Hammock into a Profile HMM, and with the former we can calculate the pairwise
alignments of two different HMMs and a sequence dissimilarity value that can be
used as a “distance” between two HMMs. With such a distance, we can create trees
and identify groups of similar Hammock results, in order to check the presence of
similar clusters among different mice.
14.3 Hammock
The Hammock program [149] can find conserved positions inside large repertoires
of short linear sequences. The basic idea of the algorithm is a progressive cluster
growth. A few sequences are considered as seeds of new clusters, followed by
iterative cycles of two alternating steps: a cluster extension step, where sequences
are inserted into the previously formed clusters, and a cluster merging step, where
whole clusters are compared and merged.
Two other papers adopting the same progressive clustering growth strategy can
be found in the literature: [170] and [171]. Both address the same aims, but [149]
could combine the best features and ideas of the previous two with state-of-the-art
of bioinformatics tools.
14.3.1 Workflow
As mentioned, the basic idea is a progressive cluster growth. The workflow can be
outlined as follows
1. Pre-processing: All duplicate sequences are removed, and the number of du-
plicates is preserved. The sequences are then sorted by length.
2. Initial greedy clustering: the aim of this step is to identify a small group of
very similar sequences using the “Database complexity reduction algorithm”
[78], in which:
(a) First sequence is used as new cluster seed.
(b) From the second onwards: the sequence is compared, and if its similar-
ity is higher than a pre-defined threshold, it became part of the cluster.
Otherwise, it forms a new cluster seed.
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3. Cluster selection and alignment: A multiple sequence alignment of all cluster
is generated.
4. Cluster extension: Groups are turned into Profile HMMs, which are then used
to search for similar sequences. Any sequence with e-value higher than a
threshold is added into the appropriate group. HMMer is used for both HMM
construction and sequence search (hmmbuild, hmmsearch). Local align-
ments are performed using ClustalΩ.
5. Cluster merging: Some clusters may be very similar to each other.
(a) Similar clusters are identified and merged into larger clusters.
(b) Local HMM-HMM alignment routine provided by HH-suite [166] is
used to measure cluster-cluster similarity.
(c) The cluster merging step is a bottom-up hierarchical clustering process
(the strategy adopted remind the UPGMA algorithm).
(d) It runs in O(n2) and it merges only the most similar pair in every step.
6. Iterating the extension and merging steps: Extension and merging steps are
repeated (three times by default).
7. Measure of clustering quality using Kullback—Leibler divergence (KLD)
[170].
8. Sequences consensus creation (WebLogo [172][173]).
14.3.2 Consideration
The Hammock program algorithm has been specifically designed to cluster short
peptide sequences, therefore making it suitable for 16 amino acids average-long
CDR3s. It can cluster large amounts of data containing noise, and produce multiple
sequence alignments of high-quality clusters.
There are no limits in terms of origin and format that can be used as input to
the program —this includes any set of peptide sequences, and even other clusters
previously originated by the program itself.
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The program does not require any prior data knowledge. It is faster, if com-





With the application of Hammock to the CDR3 repertoires, I planned to find the
most conserved amino acids and positions, common to all repertoires and to identify
emerging sequence motifs that would characterise the different mice groups.
With a special focus on mice repertoires immunised with different antigens, I
wanted to highlight the different strategies against the antigens adopted by different
mice groups. I hoped to find common, rather than unique, response strategies among
mice of the same group.
As mentioned in the introduction, there are many papers in the literature dis-
cussing the role of public sequences in the repertoires of different individuals. In
my analysis, I found the presence of several shared CDR3 sequences among the
repertoires. This value was not particularly high but still relevant, with an average
of a tenth of the total sequences shared.
In this chapter, I investigate the presence of public and private sequence within
the repertoires. But not looking at the CDR3 sequences but focusing upon the motifs
that can emerge from the repertoires.
I start by searching for the presence of motifs within each mouse, and then
group the mice immunised with the different antigens (OVA and CFA mice) and
analyse the results.
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15.2 CDR3 Boundaries
In Figure 15.1, showing a sample of a few motifs obtained by Hammock and plotted
using WebLogo [172][173], we can see clearly that the motif C, ... ,FG[X]G is
present and repeated in all figures.
Figure 15.1: Results of Hammock on the entire CDR3 sequence: Here are six randomly
chosen examples of the results of using the Hammock on the entire sequence
of CDR3. With these plots we can see that the program has found the con-
servative borders of the CDR3 thus the C and the FG[X]G motif. These were
already known, and they are actually the motifs that define the CDR3 itself.
Therefore, the program proved itself by founding the conserved position I was
expecting to find. For improved clarity, I used only sequences with the length
of 17 AA.
Indeed, Hammock looks for the most conserved position among all sequences,
using as a reference the most conserved amino acid and positions. But as we saw in
the introduction, the CDR3 itself is defined by two border regions: the cysteine on
the N-terminal of the sequence and the FG[X]G motif on the C-terminal. Indeed,
what the program found are the fixed positions that define the CDR3 itself, redis-
covering the boundaries that helped to fix the concept of CDR3 in the first place,
and that are used by all programs to determine the CDR3 from the TCR sequence.
This is far from a negative result, as it proves the effectiveness of the program and
can be considered a valid “positive control” for my investigation.
In the motifs present in Figure 15.1, the N-terminal end (left-hand side) is
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present as a cysteine residue, and on the C-terminal end (right-hand side) lies the
motif FG[X]G, where X is E, P, K, G, A, S or H.
In Table 15.1, the number of clusters found by Hammock in the mouse reper-
toires is reported. We see that the number of clusters is relatively low, and often
all sequences are reassembled in one cluster. All sequences are gathered together,
following the already-known conserved pattern common to all sequences.
Repertoire Clusters Repertoire Clusters
Control 1 1 2 Day 7 5 3
Control 1 2 1 Day 14 1 1
Control 1 3 1 Day 14 2 5
Control 1 4 1 Day 14 3 2
Control 1 5 1 Day 14 4 3
Control 1 6 1 Day 14 5 2
Control 2 1 4 Day 14 6 1
Control 2 2 1 Day 60 1 1 2
Control 2 3 3 Day 60 1 2 2
Day 5 1 2 Day 60 1 3 1
Day 5 2 2 Day 60 1 4 2
Day 5 3 3 Day 60 1 5 3
Day 5 4 2 Day 60 1 6 1
Day 5 5 3 Day 60 2 1 2
Day 5 6 4 Day 60 2 2 4
Day 7 1 5 Day 60 2 3 3
Day 7 2 4 Day 60 2 4 3
Day 7 3 6 Day 60 2 5 5
Day 7 4 4 Total: 95
Table 15.1: CDR3 Boundaries: This table presents the number of clusters found by Ham-
mock per mouse. Because the program tracks only the conserved amino acids
and those are always C ... , FG[X]G the number of resulting clusters is very
small and, they are all variation of the border. Column description: In the
columns Repertoire are listed all the 37 mice repertoire: Control 1: control
mice from the first experiment; Control 2: control mice from the second exper-
iment; Day 5: Mice sacrified 5 days post-immunisation; Day 7: Mice sacrified
7 days post-immunisation; Day 14: Mice sacrified 14 days post-immunisation;
Day 60 1: Mice sacrified 60 days post-immunisation, from the first experi-
ment; Day 60 2: Mice sacrified 60 days post-immunisation from the second
experiment. In Clusters the number of clusters in which the all sequences of
each repertoire are gathered. In the last row Total: the sum of all clusters found.
However, if we look at Figure 15.1, we note that other emerging patterns are
present at the positions immediately after the first C and before the FG[X]G motif. I
15.3. V and J region tails 148
decided to investigate these by physically removing the C and FG[X]G amino acids
from all sequences, and then running the program again.
15.3 V and J region tails
When I repeated the program on the CDR3 sequences without the borders motifs,
the result was not entirely different from the previous result. A similar number of
clusters per mouse is in evidence (see Table 15.2). A random selection of the motifs
is reported in Figure 15.2.
Figure 15.2: Results from Hammock without the CDR3 boundaries: These six ran-
domly chosen examples represent a sample of the 88 clusters found with Ham-
mock. We can note two emerging positions: a single, very conserved triplet
on the left-hand side of the pictures; and to the right, a group of four-five
amino acids. These two regions are the remaining “tails” of the V and J re-
gions, involved in the creation of the CDR3 during the V(D)J recombination.
Furthermore, if we look closer to the bottom left, we can see the presence of
a third smaller motif in the centre of the CDR3. It was this that led me to run
the Hammock program once again, with sequences stripped of borders and
V/J tails.
These results show the emerging motifs of the last part (or “tails”) of the V and
J region. The CDR3 boundaries correspond to the definition we gave to the CDR3,
and these two tails are what I consider to be the result of the V(D)J recombination
15.3. V and J region tails 149
processes explained in the introduction.
Repertoire Clusters Repertoire Clusters
Control 1 1 2 Day 7 5 5
Control 1 2 2 Day 14 1 1
Control 1 3 2 Day 14 2 3
Control 1 4 1 Day 14 3 1
Control 1 5 1 Day 14 4 3
Control 1 6 1 Day 14 5 1
Control 2 1 2 Day 14 6 1
Control 2 2 2 Day 60 1 1 1
Control 2 3 1 Day 60 1 2 2
Day 5 1 4 Day 60 1 3 2
Day 5 2 2 Day 60 1 4 2
Day 5 3 2 Day 60 1 5 2
Day 5 4 2 Day 60 1 6 3
Day 5 5 1 Day 60 2 1 5
Day 5 6 1 Day 60 2 2 2
Day 7 1 3 Day 60 2 3 4
Day 7 2 5 Day 60 2 4 4
Day 7 3 4 Day 60 2 5 2
Day 7 4 6 Total: 88
Table 15.2: V and J region tails motifs: Number of V and J region tails motifs present in
each mouse using Hammock. For this step the number of motifs is even smaller
of the one in Table 15.1. With several mouse sequences gathered in only one
cluster. Columns description as Table 15.1.
Looking at Figure 15.2, we can see that the V region (on the left-hand side of
the picture) seems to be stable, with the common pattern “ASS”. Meanwhile, the
J region (right-hand side), has a different type of structure with different types of
combinations.
I proceeded to split all sequences in the two datasets, one with the first three
amino acids and one with the last four positions of the CDR3. More simply —one
for the V region tail, one for the J region tail.
The results of the analysis of the V region show a small variation in terms of
triplet variability in the V region. See Figure 15.3.
I ran Hammock again using this time the J region only. This resulted in twelve
different clusters, but without some clear motifs. This small patch of the CDR3
sequence is too small and variable to produce a clear motif.
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Figure 15.3: V region of the CDR3 in the repertoires: Here, I plotted the most common
motifs emerging from my CDR3 formed by the first triplet after the first Cys-
teine. In order, they are: ASS (61.42%), ASG (16.87%), ASR (3.82%), AWS
(3.35%), GAR (1.73%), SAD (1.1%), all other triplets are lower than 1%. The
dominant V region triplet is ASS: the motif that we have already encountered
as one of the selected triplets with the 1-DBF.
Furthermore, if we look more closely at the picture in the bottom right of Fig-
ure 15.2, we can see the presence of a third smaller motif, in the centre of the CDR3.
This was the hint that led me to consider the option of running the Hammock pro-
gram, once again on all sequences stripped of borders and V/J tails.
15.4 The D region of the CDR3
From all of the original CDR3 sequences, I removed the first cysteine in the N-
terminal and the last four amino acids in the C-terminal corresponding to the
FG[X]G motif. Subsequently, I removed another three amino acids in N-terminal
(that I considered the V region) and another four from the C-terminal corresponding
to the J region. This accounted for a total of twelve amino acids removed. As such,
all sequences shorter than twelve amino acids are not present in this analysis, and
the average length of the sequence left is four to five amino acids. The results are
reported in Table 15.3.
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Repertoire Clusters Repertoire Clusters
Control 1 1 4 Day 7 5 7
Control 1 2 4 Day 14 1 11
Control 1 3 3 Day 14 2 10
Control 1 4 4 Day 14 3 6
Control 1 5 3 Day 14 4 5
Control 1 6 3 Day 14 5 9
Control 2 1 8 Day 14 6 10
Control 2 2 7 Day 60 1 1 7
Control 2 3 6 Day 60 1 2 2
Day 5 1 8 Day 60 1 3 4
Day 5 2 6 Day 60 1 4 5
Day 5 3 8 Day 60 1 5 3
Day 5 4 7 Day 60 1 6 5
Day 5 5 11 Day 60 2 1 10
Day 5 6 8 Day 60 2 2 8
Day 7 1 7 Day 60 2 3 4
Day 7 2 7 Day 60 2 4 6
Day 7 3 4 Day 60 2 5 4
Day 7 4 8 Total: 232
Table 15.3: Number of putative binding site per mice: In this table has been reported the
number of central or putative binding site for each mouse-repertoires, as we
can see this is the table with higher number of clusters and variation. Columns
description as Table 15.1.
We can see that the number of clusters found in this experiment (Table 15.3)
is 232, and this value is much higher than in the other experiments: 95 (Table 15.1)
and 88 (Table 15.2). This result suggests that this central part of the CDR3 is the
bigger source of variability for the CDR3 sequences.
Notably, the number of clusters is slightly proportional to the number of unique
sequences of mice, as we can see in Figure 15.4.
Unsurprisingly, a higher variability of the repertoires and the consequence
number of resulting clusters correspond to an increasingly higher number of unique
sequences.
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Figure 15.4: Number of clusters vs. Unique sequences This plot demonstrates the rela-
tion between the number of clusters found by Hammock in Table 15.3, and
the number of unique sequences for that sub-string of CDR3. Unsurprisingly,
a higher number of unique CDR3 sequence is correlated to a higher number
of clusters found by Hammock. The line in blue is the linear regression of the
data. Groups legend: C1 = Sequence from Control mice from the first exper-
iment; C2=Control mice second experiment; D5= Day 5; D7= Day 7; D14=
Day 14; M2 1= Two months, first experiment; M2 2= Two months, second
experiment
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15.5 Cluster class by class
Since I can now identify internal motifs on the CDR3 sequences, I am also able
to investigate whether there are unique and distinct motifs in the mice repertoires
infected with different antigens, and assess if there are unique and distinct motifs in
the mice repertoires infected with different antigens. This is due to the possibility
that, if our genetically identical mice are all infected with the same antigens, we
might see a similarity in the motifs produced as a reaction to the common stimuli
and, possibly, a higher difference between the control motifs vs. the infected mice
ones.





Table 15.4: Number of results for all mice: Number of cluster resulting from Hammock
for the mice infected by different antigens and the control mice. On the first
column is present the list of mice divided per antigen, the second presents the
number of clusters.
We can see that the number of cluster motifs is inferior to the 13 motifs present
in all mice. The CFA group have a smaller number of motifs —only 7 —while the
OVA mice have almost double the number of clusters.
In the following section we report the results separately for each mice group.
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15.5.1 All OVAs
Figure 15.5 shows the results from Hammock of all sequences originated by OVA
infected mice.
Figure 15.5: Results for Hammock for OVA mice: Results for Hammock for OVA mice.
From left to right, top to bottom the picture has been create with the following
number of sequences (rows separated by semicolon): 30,114, 50,212, 12,935;
7,398, 9,387, 9,523; 5,712, 5,709, 4,104; 10,711, 4,820, 5,664.
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15.5.2 All CFAs
In Figure 15.6, we see the results from Hammock of all sequences originated by
CFA-infected mice.
Figure 15.6: Results for Hammock for CFA mice: From left to right, top to bottom the
picture has been create with the following number of sequences (rows sepa-
rated by semicolon): 50,204, 6,522, 8,159; 8,999, 6,183, 4,644; 5,925
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15.5.3 All Controls
In Figure 15.7, we see the results from Hammock of all sequences originated by
control mice:
Figure 15.7: Results of Hammock for control mice: From left to right, top to bottom
the picture has been create with the following number of sequences (rows
separated by semicolon): 17,479, 2,197, 2,811; 2,119, 2,572, 5,041; 2,296,
3,609, 5,086
15.5.4 All sequences combined
In this run, the length of all CDR3 is much shorter than usual; as such, there is
a higher number of duplicated sequences, and the unique sequences are therefore
much lower than in all other runs. This meant I could use all the sequences in a
single Hammock run, obtaining a single result for the entire data set.
The results are the following thirteen different clusters, presented in Figure
15.8.
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Figure 15.8: The putative binding site of the CDR3: Reported here are the thirteen differ-
ent results of Hammock applied on all sequences of the dataset of repertoires.
The motifs are in the centre of the interaction between the TCR and the pep-
tide + MHC, and twelve of them have the common presence of one or more
G in various combinations. A presence of numerous glycine is already being
found in the literature [12][50], and to have found it again here could hint to
a relevance of this kind of amino acids for the CDR3 and peptide interaction.
Legend: From left to right, from top to bottom: the picture has been cre-
ated with the following number of sequences (rows separated by semicolon):
43,376, 75,258, 19,015; 10,730, 13,823, 14,064; 8,282, 6,262, 8,406; 6,400,
15,433, 8,356; 6,946.
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These thirteen motifs have some rather interesting characteristics: they are in
the centre of the interaction between the TCR and the pMHC and, because we have
already eliminated the V and J region tails, what remains is the D region of the
CDR3. Considering what we saw in the introduction (sections 3.8 and 3.9), we can
probably consider this section of the CDR3 as the primary centre of interaction with
the peptide, and of primary importance to this research.
Since all mice binding site sequences are clustered into thirteen different
groups, a few motifs are in evidence, with a limited variability.
Indeed, all thirteen motifs are a combination of the following eleven amino
acids: A, D, G, L, N, P, R, T, W, Y, with an over-representation of G.
15.6 Discussion
15.6.1 The putative Binding Site
With the use of Hammock, I divided the repertoires into a small number of high-
similarity-sequence clusters. Looking at the motifs resulting from the clusters, we
can spot the presence of three different levels of emerging conserved-areas in the
CDR3 sequences: the C, ... , FG[X]G border motif, the V and J tails, and the core of
the sequence, the D region. These three appear to be a clear division of the CDR3
β chains, and any future research should consider this division and analyse them
separately. Indeed, an important piece of future research would be to extend this
analysis to the CDR3 α chain and observe the emergent patterns.
Furthermore, the D region is to be considered one of the most important regions
of the CDR3. There are indications that this area is of primary importance for the
interaction with the peptide carried by the MHC, and probably to be considered the
binding site of the peptide. As we have seen in the introduction section 3.8 and in
Figure 3.5, this is the area conserved according to the experiment reported in [47],
and which other publications like [57] are pointing out as relevant.
With the use of Hammock, we have seen the presence of thirteen different
motifs in Figure 15.5: these 13 motifs are made of a combination of eleven different
amino acids rotating around the presence of one or more glycine, as also similarly
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observed in [174].
In the following Table 15.5, I have reported these eleven amino acids, listing
their names, side chain polarity, and charge.
Amino acid Hydrophobicity Side chain Side chainpolarity charge
A 1.8 Non-Polar Neutral
D -3.5 Acid Polar Negative
G -0.4 Non-Polar Neutral
L 3.8 Non-Polar Neutral
N -3.5 Polar Neutral
P -1.6 Non-Polar Neutral
Q -3.5 Polar Positive
R -4.5 Basic Polar Neutral
T -0.7 Polar Neutral
W -0.9 Polar Neutral
Y -1.3 Polar Neutral
Table 15.5: Summary table of conserved amino acids: In this table is present a summary
information on the eleven most conserved amino acids present in the thirteen
motifs (Figure 15.8). I obtained this list by looking at the multiple sequences
alignment files of the thirteen motifs, I have computed the frequency of each
amino acids per position and filtered out the amino acids with frequency lower
than 50%. The result is the following eleven amino acids: G, present in thirteen
motifs, A in 3, D in 5, L in 4), N in 4, P in 2, Q in 1, R in 3, T in 4, W in 1, Y 1.
The table also reports their amino acids’ hydrophobicity scale (source [175])
side chain polarity,and side chain charge (source [176]). The lower is the value
in hydrophobicity scale the more the amino acids is hydrophilic.
As we can see, the side chain polarities of these eleven amino acids are equally
distributed as either polar or non-polar. With the exception of A and L, they all have
a hydrophobic side chain, and nine out of eleven have a neutral side chain charge.
This implies that all thirteen motifs generated by these amino acids have a largely
neutral (therefore not charged) environment, suitable for protein-protein interaction.
These properties are very important, not only during the formation of the pro-
tein structure, but also for the interaction between different proteins. For exam-
ple, amino acids with charged side-chain can form ionic bonds with other charged
molecules [177]. In this case, the only charged amino acids are D (aspartic acid)
charged negatively and R (Arginine) charged positively. As we can see in Figure
15.8, one of the two is present in six different profiles, giving the neutral charged
15.6. Discussion 160
profile either a more positive or more negative charge. Only in one profile (Figure
15.8 bottom-left) they are together, and in one they are next to each other.
Looking at the side chain polarity of these amino acids, seven are polar and
four non-polar. Polar amino acids have the tendency to be on the outside of a pro-
tein, where they can form hydrogen bonds with water and other polar molecules
[178]. In addition, almost all amino acids have a hydrophilic behaviour common
to surface amino acids. These data suggest that an interaction between CDR3 and
the peptide is driven primarily by hydrogen bonds formed by the polarity of the side
chain. It suggests, too, that this occurs in a mostly neutral environment with a minor
component of positive or negative charged amino acids.
Among all thirteen profiles, the most frequently present amino acid is G
(glycine) as it is also often present around binding sites [179]. As we know from the
literature [50][174], this is the smallest amino acid with only one hydrogen as a side
chain: it can rotate easily, and it is used to add flexibility to the protein chain. How-
ever, such flexibility is usually not desirable as a structural component for molecular
conformation. Indeed, G and P (proline) are referred to as “helix breakers” because
they break the regularity of the α helical conformation. This would likely have the
direct effect of helping to keep the CDR3 loop a structurally disordered region.
We have already seen the presence of a glycine “rich region” of the CDR3 in
the Introduction, section 3.8, and Figure 3.6. We observed that this presence can be
explained either by recombinational biases of the V(D)J recombination, or by the
convergent recombination of the amino acids; in other words, the redundancy of the
nucleotide triplets.
These two theories are not mutually exclusive, moreover I would add that this
phenomenon’s presence can be explained by functional reasons. Indeed, thanks
to the glycine its small neutral side chain and the presence of other neutral amino
acids, a neutral a water-soluble area is created —suitable for the interaction with the
peptide [179].
This result seems to recall my findings with the work on the 1-DBF [17].
There, I selected twelve triplets that have been considered highly informative and
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likely relevant to the interaction with the peptide. The major part of those was found
around the fifth amino acid, and three of them have at least one G present: GQG,
GVG, TGV; very similar to the G G and GT motifs found by Hammock.
15.6.2 The motifs in Controls, OVAs and CFAs
When I applied the Hammock program to the D region for the repertoires divided
by group Control, OVAs and CFAs, I found nine, twelve, and seven clusters respec-
tively. Despite the groups being different in a number of sequence and repertoires,
the resulting motifs are not completely different when dealing with groups being
immunised with different antigens, or being simply a control. In fact, there are
similar motifs across all.
15.6.2.1 Assessing the similarity of the clusters
To have a better idea of the similarity and difference of my motifs, I needed to
develop a method that would provide me with an estimation of the ‘closeness’ of
the motifs. I chose the program HH-suite. This program is used to make database
searches of a set of sequences by converting the sequences into Profile HMMs and
searching the databases of HMMs. It is normally used to search in HMM database
like Pfam.
One way the program works is to assign a value of similarity between the query
and the different profiles of HMM in the database. Therefore, I converted my motifs
into multiple sequences alignment using ClustalΩ. This provided a suitable output
format to turn them into Profile HMMs using HH-suite and, measure the distance
between one motif/HMM to all the rest.
I applied this method to two different set of motifs: those from Control, OVAs,
and CFAs from Figure 15.8, and those from Table 15.3. Using the matrix of dis-
tance generated by HH-suite between all motifs, I could create the heat map [180]
presented in Figure 15.9 and Figure 15.10.
In Figure 15.9, using the heat map and the trees on the side, I investigated
the possibility that the different motifs originated from the different mice groups
could have produced groups of motifs that resembled the different origins. Using
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Figure 15.9: Heat map of the motifs from Control: OVA and CFA groups. On the mar-
gins, the control motifs are labelled in green, the CFA in blue, and the OVA
in red. Using the label colours, we can see that there is not a clear division of
motifs, and that those produced by a group are like the others. In other words,
there is no clear division between the groups. In the heat-map, the value of
similarity given by HH-suite is expressed by a value between 0 (blue) and 1
(white).
the colour label system (green for control motifs, blue for CFA and red for OVA), it
is possible to observe that this does not happen and that, in fact, the motifs produced
are similar to each other.
A similar result is obtained for the heat map with 232 motifs, Figure 15.10.
Indeed, the results for 232 motifs shows that there is a “gathering” of similar
motifs from the mice immunised with the same antigen.
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Figure 15.10: Heat map for all motifs: Heat map of the motifs resulting from all mice
analysed by Hammock, one by one. On the margins the control motifs are
labelled in green, the CFA in blue, and the OVA in red. Additionally, in
this heatmap, we can see that there is not a clear division of motifs, and that
those produced by one group are like the others. In the heat-map the value
of similarity given by HH-suite is expressed by a value between 0 (blue) and
1 (white).
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Apparently, the idea to use Profile HMM and the HH-suite program was a
logical progression of prior research. Indeed, a different laboratory published a new
program named pHMM-Tree [181] that creates trees of Profile HMM. The concept
and tools of this experiment were very similar to mine, although they created a
wider and more structured system, with different options in input or output. Using
my old Profile HMM, I ran pHMM-Tree program and created Figure 15.11.
The trees from Figure 15.10 and Figure 15.11 are different; however, both show
the absence of a clear difference between the motifs originated by mice immunised
with the same antigen.
With these experiments, I hoped to find the different reactions from the mice
with common immunisation, and to find motifs that would be simultaneously dif-
ferent between the mice groups and similar among themselves. In other words,
I hoped to see a plot in which OVA and CFA motifs are gathered in two distinct
groups. However, this was not the case; OVA and CFA motifs do not appear to be
intrinsically different. Although there motifs are present in some mice groups and
not in others, this is not sufficient to establish a clear trend. The reason for this is
not yet clear, and more research is required.
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Figure 15.11: pHMM-tree result using the 232 motifs: Dendrogram of the 232 mo-
tifs resulting from Hammock in which similarity has been computed using
pHMM-Tree program. On the right margins, the control motifs are labelled
in green, the CFA in blue, and the OVA in red. With this plot I am testing the
hypothesis whether repertoires immunised with same antigens would pro-
duce similar results. In the previous two pictures I used a method of my own
making using a combination of HH-suite and HMMer (see Figure 15.9) and
here I repeated the test using a newly published method pHMM-Tree [181].
Even in this case, we cannot detect large groups of similar motifs coming
from similar mice.
Chapter 16
Hammock Results as features of a
SVM classification test
16.1 Experiment Description
Here, I describe my work on a new strategy for the classification of CDR3 reper-
toires, using a combination of HMM and SVM classification methods.
In the experiments with the SVM, I encountered the presence of duplets and
triplets in all repertories and used the resulting vectors for the training/test of the
SVM. Here, instead, I am using the Profile HMM originated by the Hammock mo-
tifs as features of the SVM.
Using a program like HMMer, it is possible to convert any given multiple se-
quences alignment into a Profile HMM. And with HH-suite, it is possible to evaluate
how a new sequence is closely related to a Profile HMM. Each time I test a sequence
against a Profile HMM, I obtain a score value; if the score value is higher than a de-
terminate threshold, the new sequences could be considered a member of the Profile
HMM. For example, if I have a Profile HMM trained by a set of immunoglobulin
sequences, and I want to test if a new unknown sequence is an immunoglobulin or
not, I would test it against the Profile HMM. If the resulting score value is high
enough, the sequences will be considered part of the “family” sequence.
In the same way, if I have a sequence or set of sequences from an OVA mouse,
and I test it against a Profile HMM, and it is considered a member of the HMM, so I
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would expect that it originated from other OVA mice. Let us see this in more detail
through the workflow of this experiment:
1. I selected five sets of random 50,000 sequences from a mouse repertoire, for
example, OVA 1. I use these five sets as my test set.
2. I merged all remining OVA mice in one large group, leaving out, of course,
our test mouse. Then I divided the groups into two halves.
(a) From the first half, I selected five sets of 50,000 random sequences. This
defines my training set.
(b) I run Hammock with the second half, obtaining a group of motifs. These
motifs will be turned into multiple sequence alignments using ClustalΩ
and into Profile HMMs using HMMer.
3. All remaining CFA mice were merged together and run with Hammock, and
its results turned into Profile HMMs.
4. The features of the SVM will now be formed by all profiles originating the
CFA mice (point 3) and the second half of OVA sequences (point 2b).
5. The first half of all OVA (point 2a) was then used as training test for all profile-
HMM/SVM-feature (point 4).
6. This workflow results into five numerical vectors for the test set and five for
the training, and I could at this point perform the SVM.
Every time a new mouse was used as a test set, I needed to run a new Hammock
run, resulting in a different number of Profile HMMs. A report of these changes is
presented in Table 16.1.
While the other parts of the features formed by the motifs for all OVA and all
CFA mice stay the same, I already have the Hammock results from the analysis
shown in the previous chapter: twelve motifs for OVA mice, and seven for CFA.
When a CDR3 sequence is tested or trained against the Profile HMM list, I
cannot be sure that such sequence is considered belonging to only one Profile HMM;
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Test Mouse All w/o test Test Mouse All w/o test
CFA 1 8 OVA 2 11
CFA 2 4 OVA 3 8
CFA 3 5 OVA 4 8
CFA 4 6 OVA 5 10
CFA 5 5 OVA 6 11
CFA 6 9 OVA 7 11
CFA 7 6 OVA 8 11
CFA 8 5 OVA 9 6
CFA 9 9 OVA 10 10
CFA 10 8 OVA 11 4
CFA 11 5 OVA 12 6
CFA 12 5 OVA 13 4
CFA 13 7 OVA 14 10
OVA 1 10 OVA 15 10
Table 16.1: Number of clusters per groups: In this table are reported the number of ham-
mock clusters formed by all mice immunised with the same antigen, less the
test mouse. Every time, I test a mouse repertoire for an SVM with profile-
HMM as feature, I need to re-run Hammock. As a consequence, the number of
Profile HMM for that class of mice, in this case OVA or CFA, changes.
however, my assumption is that a higher number of sequences from one particular
test class will be considered part of that trained class. This majority of sequences
would drive the SVM to classify the repertoire correctly.
In Table 16.2 the results of the experiment are reported:
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Mice Classified Mice Classified
OVA 1 0 OVA 15 1
OVA 2 0 CFA 1 0
OVA 3 1 CFA 2 1
OVA 4 1 CFA 3 0
OVA 5 1 CFA 4 1
OVA 6 1 CFA 5 0
OVA 7 1 CFA 6 0
OVA 8 1 CFA 7 1
OVA 9 0 CFA 8 0
OVA 10 0 CFA 9 1
OVA 11 1 CFA 10 0
OVA 12 1 CFA 11 0
OVA 13 1 CFA 12 1
OVA 14 1 CFA 13 0
57%
Table 16.2: Results for the SVM+HMM classification experiment: Here are listed all 28
immunised mice, with their classification result (1 if correctly classified, 0 if
not classified correctly). The assignment is given by a majority of test vectors
assigned (3 out of 5). The result of 57% is not high, and indeed, only slightly
more successful than random classification. In actual fact, we could obtain a
value of 53.6% by classifying all as OVA.
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16.2 Discussion
With this experiment, I aimed to merge two important and well-known machine
learning techniques and create another use for the motifs found by Hammock (in
addition to creation of the heat-map, section 15.6.2).
Unfortunately, as for the case seen in Figure 15.9, Figure 15.10 and Figure
15.11, the motifs found in the mice repertoires are too similar to each other. As
such, this did not allow me to have a clear classification of the test/train set of
sequences, nor distinct numerical vectors for the SVM.
This method combines a great number of programs and techniques: Hammock
for the motifs; ClustalΩ for the multiple alignments; HMMer for Profile HMM
creation; HH-suite for test sequences vs. HMM; and SVM for the classification.
Despite the result of this experiment being low and not promising, I cannot say
that this workflow is totally erroneous. It is likely that, with a different set of HMM







In this thesis, I have reported my research on the use of machine-learning methods
for the classification of the CDR3 sequences, the analysis of repertoires, and the
interpretation of the results, given the current literature. This doctorate project falls
under the overall aim of Professor Chain’s lab of understanding the functioning of
T-cell immunity by developing computational methods for the analysis of the TCR
repertoire.
As I demonstrate in the Results section of this thesis, the T-cell receptor plays
a crucial role in the immune system: comprehending its mechanisms is vital for
the progress of research in immunology. There are still many unanswered ques-
tions regarding the TCR, especially regarding its interaction with peptides carried
by MHC. Although, on one hand, the interaction between peptides and MHC is well
known [18][19][20] and there are many computational models with which to predict
it [182][183], on the other, there are few papers on TCR and peptides interaction and
none at all on the model proposed within this study.
17.1 Current Challenges in the TCR repertoires
studies
A number of major challenges remain in interpreting T-cell receptor repertoire data.
As we have seen, the protein is composed of two distinct chains (α and β ). These
are paired in the structure; but most methods for sequencing large numbers of TCRs
do not retain the pairing information (pairing problem). Researchers are trying to
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avoid this problem through single cell sequencing [184][185].
Furthermore, β chains are historically the main target of studies because of
their higher variability (due to the D region) [186][187]. Therefore, the number of
α chains in the literature is lower.
Another major issue in the study of TCR is the absence of research about the
large sets of crystal structures of the TCR, bound to MHC/ peptide. X-ray crys-
tallography is understandably difficult, and to be able to capture the two molecules
(TCR and MHC) and the peptide during the protein interaction results in few ternary
(MHC-peptide-TCR) complexes.
All these issues have a bearing on the study of the CDR3, the little patch of
TCR which is considered to play the major role in the interaction concerning CDR3
sequences.
Aware of these limitations, I conducted my doctoral research by proceeding
from the most common and basic analytical techniques, and gradually increasing
the complexity of the methods. In doing so, I began by using the methods common
to existing literature —such as statistical and quantitative analysis of the repertoires
—and subsequently extended these to more recent, advanced machine learning tech-
niques.
17.2 The Data-Set: CDR3 numbers, sharing and di-
versity
This thesis is based entirely upon a set of TCR sequences obtained from our collab-
orators (Friedman Laboratory at the Weizmann Institute). The data were obtained
when repertoire sequencing by high-throughput sequencing was in its infancy, and
the library preparation and sequence quality have since been improved. Neverthe-
less, the data set is an interesting starting point for an analysis of TCR repertoire
and its relationship to specificity [16][17][69].
In chapter 4 I have reported the statistical and quantitative analysis of the 37
murine β -chain CDR3 repertoires used in the thesis. The collection of TCR β
chains from splenic CD4+ T cells resulted in a large difference in the number of
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sequences per repertoire, ranging from a few hundreds of thousands in the Control
mice to several million in the Day 7 mice, (see section 3.6).
This discrepancy in numbers is reflected to a lesser extent in the number of
unique sequences (section 4.3). The standard deviation for the whole database
passes from 2.6 · 106 for all sequences to 1.4 · 105 for all unique sequences. Inter-
esting to be noted is that the number of unique sequences seems to reach a plateau
when at least a million CDR3 sequences are recorded. I posit that we can con-
sider one million sequences as the minimum number of CDR3 required to have an
acceptable representation of the internal variability of the whole CDR3 repertoire
within the body.
Another confirmation of previous studies is the average length of the CDR3.
If we consider the C and FG[X]G motif present at the beginning and end of the
sequence, the total length is 16 amino acids (see Figure 4.7) with a variance of 3.55
amino acids. Although the median of sequences is formed by 17 amino acids, the
high number of very short sequences pushes the mean to a lower value.
From the analysis of the repertoire, we have also seen two other important
indexes: the Jaccard Index and the Gini coefficient.
With the former, we can see that —despite all the mice being genetically iden-
tical —the type of CDR3 produced is substantially different and, even if immunised
with the same antigen, the immune responses produced are different. The very few
sequences shared confirms that the immunisation event alters the repertoires, but it
does not drive repertoire convergence [16]. This result proves that identical stim-
uli would not necessarily produce similar responses, and that looking at the whole
CDR3 sequence to search for the immune response strategy is not the right move.
Indeed, the number of shared and private sequences is not dissimilar within a small
number of genetically identical mice or a large population of unrelated individuals.
Finally, with the Gini coefficient, we saw that the event of immunisation does
not push the repertoire to an over-representation of one or a few sequences, but that
immunised repertoires continue to be extremely diverse and contain a high number
of different CDR3 sequences [188].
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17.3 The significance of short protein motifs in reper-
toire classification
After the quantitative analysis of the repertoires, I considered the application of
different bioinformatics tools and methods. At the beginning, I started using the
common tools of sequence analysis (such as using alignment models like ClusterΩ
to create a consensus of the CDR3) to plot sequence logos and try to create profiles
of sequences in order to highlight families of sequences and produce phylogenetic
trees.
However, I realised quickly that these methods were unfeasible for these kinds
of protein sequences. The length of sequences is too short, with too much variation:
these methods would be unable to produce multiple sequence alignment with any
meaning. Even if we were using sequences all of equal length, like all sequences of
16 amino acids, the results would be still unusable for identifying variations in the
different kinds of CDR3 repertoires.
Other bioinformatics methods for protein structural analysis, like building by
homology, are not enforceable because we do not have the information for the α
chain. The solution we adopted —and the main topic of this thesis —is to utilise
the methods of classification to explore the property of the repertoires. If we were
able to create a valid prediction tool for the classification of the repertoires, we could
verify whether the same features used by the tool also have a biological relevance.
This concept was previously adopted by the lab and published in [16]. Therefore, I
reviewed this initial work and extended the method to a new set of repertoires just
sequenced, which I called Group B (see Section 4.2).
17.4 Experiments
17.4.1 Repertoire classification using SVM
My work on [16] is reported in chapters 5, 6, 7 and 8, including an introduction to
the methods, my review of the workflow, and the results.
I analysed the work done in [16], using some of the core ideas behind it. In
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this study, thanks to the use of numerical factors and k-means algorithm mean it
has been possible to decrease the complexity of the data and reduce the very large
number of CDR3s in each repertoire to a smaller number of numerical features. It
was possible to convert the string of amino acids into actual numerical vectors and,
with the Support Vector Machine, to have a high value of success rate.
I explored several of the method’s parameters. I compared the results of con-
verting amino acids to numerical vectors, using Atchley factors to capture the physi-
cal/chemical properties of the amino acids along with two other related sets of such
factors (Sandberg, Kidera). In order to test the importance of this conversion, I
also used an arbitrary conversion which yielded a similar set of numerical values,
but which did not contain any implicitly biological meaning. Using these different
feature sets, I tested the results of the k-means using different numbers of clusters,
extended the bag of words using duplets and other p-tuples not reported in this the-
sis, and tried different SVM kernels.
Unexpectedly, it became apparent that the simple counting of p-tuples in reper-
toires (for example, the frequency of the 8,000 possible triplets) was sufficient to
give good classification performance using the SVM, without any prior feature re-
duction or clustering steps. Thus, clustering of amino acids according to chemical
or physical properties did not seem to be important for repertoire classification.
With the workflow of [16], I carried out the classification of the repertoire fol-
lowing two main aims: the classification of repertoires based on their sacrifice date,
and classification based on the antigen with which they were immunised, repeating
the experiment for Group A (data from the first experiment) and Group A and B
combined (all data). All results are reported in section 8.1.
For the classification based on the sacrifice day, the results are relatively high
for duplets and triplets, with values between 70% and 81% (check Table 8.9 and
Table 8.10). These values are high but they suffer from a few misclassifications, and
more if compared with [16]. This is, due to different subsampling of the data, the use
of default in-function SVM parameters used during the process of SVM training.
This does not, however, diminish the conclusions that can be drawn. Firstly, that the
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immune response is carried by a large numbers of low frequency CDR3 with shared
features (p-tuples); and secondly that, in addition, there is not a dominant clonotype
and both high and low frequency p-tuples contribute to the immune response.
Events of immunisation can profoundly change the repertoires, such that to
distinguish and to classify control repertoires versus immunised mice is the easiest
of all classification. More difficult is the classification of immunised mice, and this
suggests that each individual generates a seemingly unique response. However, with
the progressive advance of the classification method, I believe that we will be able
to use these low-level features in approaches for the analysis of clinical samples that
will be more and more reliable.
For classification of repertoires based on antigen stimulation, i.e. the ability
to distinguish between CFA+OVA and CFA which were not reported in the paper
[16], the OSR is not high, with an average success rate of 64%. This is slightly
higher than random classification, but not enough to pursue in the application of
this method, for the classification of different antigen-immunised repertoires. It is
hard to say why one type of classification works better than the other, and this is
probably due to various different factors. One is probably the fact that control mice
are easily correctly classifiable, while in OVA vs. CFA classifications, Control mice
are absent.
Also, especially regarding the classification of OVA vs. CFA, the mice reper-
toires have been collected in a non-optimal time frame; in C57BL/6 mice, the CD4+
T cells have a peak of response around 9 days, after the two first collection points
(day 5 and 7), followed after a first half-life phase after 3 days, therefore before the
third time point (day 14) and, a second half-life phase after 35 days, way before the
fourth time point (day 60)[189].
17.4.2 1-Dimesion Bayesian Function
At this point of the study, my focus was to find a different method to classify the
OVA vs. CFA. At that time, I noticed that if I decreased the number of p-tuples
(all duplets, triplets etc.) used for the SVM classification, the OSR could increase
dramatically.
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Intrigued by this idea, I decided to see if it was possible to select a valid subset
of features; that is, a not arbitrary subset of features, that could increase the success
rate, and might be later considered as having biological relevance.
I started by selecting a p-tuple at the time and iteratively trying to classify it
as belonging to OVAs or CFAs repertoires. Then, sorting them from the highest to
lowest classification rate, and using a progressively larger subset of features, until
I had the best CDR3 success rate. Indeed, if a single feature can correctly classify
itself, perhaps, a small collection of features with the same characteristic would lead
to greater OSR in the overall CDR3 classification. After a few attempts, I applied
the formula of the 1-Dimensional Bayesian Function (1-DBF). This function can
evaluate the likelihood of an element being part of one of two classes, using the
mean and standard deviation of the samples. This process worked well, and I could
boost the success rate from the OVA vs. CFA, from 61% to 94% using only twelve
triplets. This work was later published in [17].
The principal part of this work was to use an initial step to select a limited
number of relevant features, and then to use these in a non-linear SVM thus reduc-
ing the noise/over-fitting but retaining the flexibility of the non-linear kernels. An
alternative approach to achieve this end was explored by another PhD student in our
group [69] —this was using linear boosting and 1-norm optimisation for automatic
feature selection.
In [17], I combined two different machine learning methods —Bayes and SVM
—using the features selected from the former as input into the latter. Therefore, I
had to use two different test sets, an inner and an outer test, to avoid any danger that
success rate derived from overfitting. Indeed, in my first iteration of this workflow,
I did not consider this eventuality, and all my result were 100% accurate. This was
clearly a methodological mistake. As previously mentioned, this kind of approach
has been repeated in different studies in recent years [125]-[132]. This suggests
that this method holds potential, and I would like to extend the research to other
datasets.
With this classification system, I isolated 12 triplets that seemed to have a real
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biological meaning and relevance in terms of amino acid positions and composition.
Interestingly, some of the triplet expressing combinations of glycine will return in
my work with Hidden Markov Models.
17.4.3 HMM based analysis and classification
In the last part of my thesis, I focused upon the use of HMM-based programs for
the classification and analysis of my repertoires. I sought a way to apply Markov
Chain and HMM methods for the majority of my doctorate. I knew that HMMs are
one of the most used machine learning techniques for sequence analysis [150], and
I tried different approaches to find families of sequences within the database, and
try to classify the repertoires, but with scarce results, which have not been reported
here.
With the publication of the Hammock program [149] I could identify the three
areas of CDR3 (reported in chapter 15), to identify protein motifs for each group of
mice, to create phylogenetic trees of the motifs (a similar concept is published in
[181]), and I was able to use and combine many programs and techniques available
in the literature. Although, with these methods, I could not produce valid classi-
fication methods (chapter 16), I think this is the part of my research in which we
have the best and cleanest results in terms of visualisation and analysis of the entire
CDR3 repertories.
First, we had a clear view of the CDR3 repertoires in a single plot. We could
see and identify three different parts of the CDR3: 1) the borders of the sequences
(C, ... , FG[X]G), that confirms what was already reported in the literature; 2)
the presence of a V and J “tails” within the CDR3; 3) the presence of a numerous
combination of glycine forming motifs and patterns that, until this point, had not
been considered.
17.5 Future Work
It would be worth repeating the analysis with the 1-DBF with new data and com-
paring their results. I am curious to see whether the resulting motifs found on the D
region of the CDR3 can change, and how much, with respect to different repertoire.
17.5. Future Work 180
In doing so, I would hope to conclude if the motifs found are unique or shared.
I think that a deeper analysis of the results of Hammock —concerning motif
presence and composition —would be important and highly relevant for a future
study. I conducted a small research project on this during the last period of this
study (section 15.4), but this should be extended.
Furthermore, obtaining repertoires of α and β -chain CDR3s combined would
be a fruitful line of enquiry. Indeed, I am convinced that the study of motifs and
patterns within the CDR3 repertoires is the path for this field to follow, as other
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